(522429, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131307', 'abnormally decreased number of mitotic cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522430, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0142066', 'abnormally increased number of desmosome', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(522431, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102147', 'abnormal somatic stem cell morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522432, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127364', 'abnormally localised multiciliated cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522433, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0142051', 'abnormal cerebrospinal fluid', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(522434, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127399', 'abnormally localised melanoblast', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522435, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0133445', 'abnormally increased number of cilium in the ciliated non-epidermal cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522436, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0130979', 'abnormally increased number of Merkel cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522437, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100339', 'abnormal circumblastoporal collar', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522438, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125530', 'absent chondroblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522439, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107325', 'abnormal adult thrombocyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522440, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131561', 'abnormally localised actin filament', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522441, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0124845', 'absent stem cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522442, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141438', 'increased cell population proliferation in tadpole', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522443, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125160', 'absent exocrine cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522444, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100802', 'abnormal exocrine cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522445, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100956', 'abnormal centrosome', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(522446, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101074', 'abnormal germinal vesicle', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(522447, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135716', 'increased cell population proliferation in portion of organism substance', 0.4411764705882353, 5.835653092541957, 1.6045413160604438, 'HP:0011017', 'Abnormal cellular physiology'),
(522448, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100152', 'abnormal alimentary system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(522449, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100231', 'abnormal compound organ', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522450, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101071', 'abnormal endoplasmic reticulum', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(522451, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102183', 'abnormal oocyte cortex morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522452, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127372', 'abnormally localised polar body', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522453, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125061', 'absent basal body', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522454, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100004', 'abnormal cell', 0.65, 3.6715585125471644, 1.5448343060521594, 'UPHENO:0086172', 'abnormal cell'),
(522455, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0115615', 'abnormally posteriorly mislocalised primordial germ cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522456, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136478', 'increased cell population proliferation in thoracic region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522457, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102608', 'abnormal multiciliated cell morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522458, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131189', 'abnormally decreased number of stem cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522459, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107399', 'abnormal filopodium morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522460, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131314', 'abnormally decreased number of exocrine cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522461, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101362', 'abnormal vegetal cortex', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(522462, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101535', 'abnormal absorptive cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522463, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141787', 'abnormal hormone metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522464, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131553', 'abnormally localised Roux spot', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522465, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141791', 'abnormal primary metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522466, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138578', 'decreased cell population proliferation in anatomical system', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522467, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103145', 'abnormal basal body morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522468, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100114', 'abnormal peripheral nervous system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(522469, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135322', 'increased cell population proliferation in marginal zone (sensu neural)', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522470, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138577', 'decreased cell population proliferation in anatomical group', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522471, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139622', 'decreased cell population proliferation in dorsal region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522472, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0115508', 'abnormally peramorphic growth of whole organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522473, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100293', 'abnormal duct', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522474, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127643', 'abnormally localised somatic stem cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522475, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131351', 'abnormally decreased number of apoptotic cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522476, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102539', 'abnormal cytoplasm morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522477, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139717', 'abnormally necrotic cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522478, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102636', 'abnormal acid secreting cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522479, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125013', 'absent early embryonic cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522480, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126318', 'abnormally localised cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(522481, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100732', 'abnormal tendon fibroblast', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522482, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138581', 'decreased cell population proliferation in male organism', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522483, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100924', 'abnormal spermatozoon', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522484, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100745', 'abnormal anterior lymph sac', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(522485, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141272', 'absent surface breathing', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(522486, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107262', 'abnormal left-right axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522487, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100335', 'abnormal commissural interneuron', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522488, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101187', 'abnormal dorsolateral commissural neuron', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(522489, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126628', 'abnormally localised blastomere', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522490, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103179', 'abnormal lampbrush chromosome morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522491, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0129551', 'increased size of the cell part', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522492, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135476', 'increased cell population proliferation in anatomical system', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522493, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135613', 'increased cell population proliferation in anatomical cluster', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522494, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135474', 'increased cell population proliferation in anatomical structure', 0.4411764705882353, 5.835653092541957, 1.6045413160604438, 'HP:0011017', 'Abnormal cellular physiology'),
(522495, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100344', 'abnormal portion of organism substance', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522496, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135788', 'increased cell population proliferation in intersomitic region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522497, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139669', 'decreased cell population proliferation in ventro-lateral region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522498, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138579', 'decreased cell population proliferation in whole organism', 0.42857142857142855, 5.835653092541957, 1.5814531869511603, 'HP:0011017', 'Abnormal cellular physiology'),
(522499, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101358', 'abnormal endothelial cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522500, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126697', 'abnormally localised proepicardium', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522501, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131110', 'abnormally increased number of paracrine cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522502, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107311', 'abnormal apical junction complex', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(522503, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0142052', 'abnormal nasal region', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(522504, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100882', 'abnormal perichondrial cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522505, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101467', 'abnormal alkali secreting cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522506, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135718', 'increased cell population proliferation in anatomical line', 0.4411764705882353, 5.835653092541957, 1.6045413160604438, 'HP:0011017', 'Abnormal cellular physiology'),
(522507, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0124716', 'absent cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522508, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101297', 'abnormal barrier cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522509, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100386', 'abnormal limb', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(522510, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102069', 'abnormal proepicardium morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522511, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125833', 'absent kinetochore', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522512, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103037', 'abnormal ring structure morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522513, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100196', 'abnormal neuron', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(522514, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100028', 'abnormal anatomical cluster', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522515, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131725', 'abnormal phosphorylation of RNA polymerase II C-terminal domain', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(522516, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100216', 'abnormal hepato-pancreatic progenitor cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522517, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125715', 'absent barrier cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522518, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100192', 'abnormal epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522519, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127288', 'abnormally localised pericyte', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522520, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101461', 'abnormal sperm entry point', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(522521, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131707', 'abnormal cilium assembly', 0.5172413793103449, 5.835653092541957, 1.7373661832679608, 'HP:0011017', 'Abnormal cellular physiology'),
(522522, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131569', 'abnormally localised cortical actin cytoskeleton', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522523, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135478', 'increased cell population proliferation in female organism', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522524, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0130964', 'abnormally increased number of cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522525, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136525', 'increased cell population proliferation in postero-dorsal region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522526, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125523', 'absent acid secreting cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522527, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100901', 'abnormal blastomere D1.2.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522528, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102353', 'abnormal centromere morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522529, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100917', 'abnormal stage III oocyte', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(522530, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100674', 'abnormal secondary oogonium', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(522531, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101113', 'abnormal stage IV oocyte', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(522532, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141715', 'abnormal septum', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522533, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141781', 'abnormal secondary metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522534, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107261', 'abnormal dorsal-ventral axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522535, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131129', 'abnormally increased number of chondroblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522536, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131347', 'abnormally decreased number of myelin accumulating cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522537, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100273', 'abnormal visual system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(522538, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103067', 'abnormal paracrine cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522539, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102520', 'abnormal microtubule morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522540, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101490', 'abnormal ectodermal cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(522541, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100721', 'abnormal centromere', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(522542, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141266', 'abnormal surface breathing', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(522543, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100701', 'abnormal microglial cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(522544, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135736', 'increased cell population proliferation in cell condensation', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522545, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0142065', 'abnormally decreased number of desmosome', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522546, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102965', 'abnormal barrier epithelial cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522547, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127428', 'abnormally localised endoplasmic reticulum', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522548, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135131', 'increased cell population proliferation in hindlimb region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522549, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126473', 'abnormally localised germ cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522550, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100277', 'abnormal blastocoel', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522551, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125115', 'absent paracrine cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522552, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0130986', 'abnormally increased number of germ cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522553, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101378', 'abnormal blastomere D1', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(522554, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100551', 'abnormal oocyte cortex', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(522555, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100573', 'abnormal extraembryonic structure', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522556, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101350', 'abnormal blastomere D2.1.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522557, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101200', 'abnormal joint region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522558, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125743', 'absent lampbrush chromosome', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522559, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100574', 'abnormal gastrula cell', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(522560, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102061', 'abnormal spermatid morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522561, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141289', 'abnormal spindle microtubule morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522562, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131559', 'abnormally localised spindle microtubule', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522563, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102693', 'abnormal plasma membrane morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522564, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100599', 'abnormal adult immune system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(522565, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101325', 'abnormal blastomere D2.1.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522566, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101917', 'abnormal progenitor cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522567, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126454', 'abnormally localised stem cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522568, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100626', 'abnormal primordial germ cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(522569, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0133441', 'abnormally increased number of cilium in the ciliated cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522570, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141795', 'abnormal glycosylation', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522571, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103021', 'abnormal wedge region morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522572, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101472', 'abnormal zygote cortex', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(522573, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101463', 'abnormal right-ventral blastomere', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(522574, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131061', 'abnormally increased number of keratin accumulating cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522575, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102285', 'abnormal myoblast morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522576, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:00000000', 'Xenopus phenotype', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(522577, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125997', 'absent Merkel cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522578, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136524', 'increased cell population proliferation in antero-ventral region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522579, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107272', 'abnormal axial region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522580, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107286', 'abnormal efferent neuron', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(522581, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127896', 'abnormally localised ring structure', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522582, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131735', 'abnormal spindle assembly', 0.5172413793103449, 5.835653092541957, 1.7373661832679608, 'HP:0011017', 'Abnormal cellular physiology'),
(522583, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101166', 'abnormal premigratory neural crest cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522584, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0142067', 'abnormally necrotic desmosome', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522585, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127029', 'abnormally localised multiciliated cell precursor', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522586, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101136', 'abnormal ooplasm', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(522587, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100762', 'abnormal intersomitic region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522588, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107324', 'abnormal embryonic thrombocyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522589, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127824', 'abnormally localised alkali secreting cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522590, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127363', 'abnormally localised barrier cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522591, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0130988', 'abnormally increased number of pericyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522592, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139580', 'decreased cell population proliferation in thoracic region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522593, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141778', 'abnormal biosynthetic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522594, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138424', 'decreased cell population proliferation in marginal zone (sensu neural)', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522595, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136398', 'increased cell population proliferation in egg jelly', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522596, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127435', 'abnormally localised mitotic spindle', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522597, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126982', 'abnormally localised secondary oogonium', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522598, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136025', 'increased cell population proliferation in joint region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522599, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100521', 'abnormal animal blastomere', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(522600, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135482', 'increased cell population proliferation in cell', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522601, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101078', 'abnormal mucous gland', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522602, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141714', 'abnormal anterior notochord', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(522603, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127089', 'abnormally localised myoblast', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522604, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131248', 'abnormally decreased number of acid secreting cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522605, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141880', 'abnormal ethanolamine metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522606, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131389', 'abnormally decreased number of barrier epithelial cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522607, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141775', 'abnormal nitrogen compound metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522608, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100754', 'abnormal electrically active cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522609, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100667', 'abnormal vegetal yolk mass', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522610, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131031', 'abnormally increased number of nucleate erythrocyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522611, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100587', 'abnormal vestibuloauditory system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(522612, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141798', 'abnormal lipid metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522613, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138844', 'decreased cell population proliferation in extracellular matrix', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522614, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135475', 'increased cell population proliferation in anatomical group', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522615, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101326', 'abnormal cementoblast', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522616, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131512', 'absent adherens junction', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522617, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100515', 'abnormal somatic stem cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(522618, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131513', 'absent actin cytoskeleton', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522619, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100203', 'abnormal endocrine cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(522620, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107263', 'abnormal anatomical side', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522621, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0128071', 'decreased size of the cell part', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522622, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101450', 'abnormal myeloid cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(522623, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100023', 'abnormal mesenchyme', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522624, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102934', 'abnormal subcortical cytoplasm morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522625, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127876', 'abnormally localised microtubule', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522626, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101409', 'abnormal perivitelline space', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(522627, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107339', 'abnormal yolk platelet', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(522628, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100861', 'abnormal blastomere D2.2.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522629, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136518', 'increased cell population proliferation in anterior region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522630, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100742', 'abnormal musculoskeletal system', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522631, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100295', 'abnormal extracellular matrix', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522632, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100363', 'abnormal cardiovascular system', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522633, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139620', 'decreased cell population proliferation in anterior region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522634, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131706', 'abnormal ciliary basal body organization', 0.5555555555555556, 5.835653092541957, 1.8005636605953823, 'HP:0011017', 'Abnormal cellular physiology'),
(522635, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139627', 'decreased cell population proliferation in postero-dorsal region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522636, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101241', 'abnormal nucleate erythrocyte', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522637, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101468', 'abnormal stage I oocyte', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(522638, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103642', 'increased cell population proliferation', 0.5172413793103449, 5.835653092541957, 1.7373661832679608, 'HP:0011017', 'Abnormal cellular physiology'),
(522639, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125693', 'absent mucus secreting cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522640, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0124807', 'absent cell part', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522641, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141841', 'abnormality of whole organism mass', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(522642, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131354', 'abnormally decreased number of multiciliated cell precursor', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522643, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100009', 'abnormal multi-tissue structure', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522644, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102356', 'abnormal kinetochore morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522645, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107253', 'abnormal enteric nervous system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(522646, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100069', 'abnormal urinary system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(522647, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101448', 'abnormal myelin accumulating cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522648, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100724', 'abnormal kinetochore', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(522649, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135720', 'increased cell population proliferation in extraembryonic structure', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522650, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131130', 'abnormally increased number of myelin accumulating cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522651, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107278', 'abnormal medial region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522652, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101120', 'abnormal cardiac progenitor cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522653, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100308', 'abnormal early embryonic cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(522654, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126681', 'abnormally localised basal body', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522655, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100954', 'abnormal neural progenitor cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(522656, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131075', 'abnormally increased number of mucus secreting cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522657, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0130973', 'abnormally increased number of stem cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522658, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141314', 'abnormal Roux spot morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522659, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141877', 'abnormal 2-deoxyribose 1-phosphate metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522660, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0124884', 'absent keratin accumulating cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522661, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127975', 'abnormally localised mitochondrial cloud', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522662, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101283', 'abnormal left-ventral blastomere', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(522663, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136521', 'increased cell population proliferation in ventral region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522664, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131551', 'abnormally localised actin cytoskeleton', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522665, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100976', 'abnormal multiciliated cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(522666, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100675', 'abnormal dorsal vegetal hemisphere blastomere', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(522667, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101110', 'abnormal cell-free extract', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522668, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136515', 'increased cell population proliferation in apical region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522669, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127821', 'abnormally localised apoptotic cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522670, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131283', 'abnormally decreased number of myoblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522671, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125644', 'absent pericyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522672, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127522', 'abnormally localised cementoblast', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522673, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102386', 'abnormal electrically active cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522674, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100396', 'abnormal dorsal animal hemisphere blastomere', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(522675, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138606', 'decreased cell population proliferation in multi-tissue structure', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522676, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100547', 'abnormal blastomere V2', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(522677, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138838', 'decreased cell population proliferation in cell condensation', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522678, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101547', 'abnormal lampbrush chromosome', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(522679, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100268', 'abnormal circulatory system', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522680, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101237', 'abnormal mucus secreting cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522681, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101504', 'abnormal blastomere D2.2.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522682, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135130', 'increased cell population proliferation in forelimb region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522683, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141267', 'abnormal resting posture', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(522684, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126725', 'abnormally localised epithelial cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522685, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101452', 'abnormal blastomere V1.1.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522686, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127631', 'abnormally localised centriole', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522687, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136321', 'increased cell population proliferation in multicellular anatomical structure', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522688, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101096', 'abnormal tendon', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(522689, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103631', 'abnormally increased number of apoptotic cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522690, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101023', 'abnormal ultimobranchial body', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(522691, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103636', 'abnormally increased number of melanoblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522692, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125750', 'absent melanoblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522693, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101107', 'abnormal erythroid cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(522694, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100205', 'abnormal limb segment', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(522695, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136567', 'increased cell population proliferation in ventro-lateral region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522696, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103167', 'abnormal absorptive cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522697, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127171', 'abnormally localised myelin accumulating cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522698, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101366', 'abnormal morula cell', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(522699, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101221', 'abnormal larval immune system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(522700, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135479', 'increased cell population proliferation in male organism', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522701, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101004', 'abnormal acid secreting cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522702, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100807', 'abnormal matrix-based tissue', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522703, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131171', 'abnormally increased number of barrier epithelial cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522704, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101940', 'abnormal early embryonic cell morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522705, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125559', 'absent electrically active cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522706, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0115391', 'abnormally undifferentiated alimentary system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(522707, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135742', 'increased cell population proliferation in extracellular matrix', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522708, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100665', 'abnormal egg jelly', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522709, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100392', 'abnormal cilium', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(522710, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138580', 'decreased cell population proliferation in female organism', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522711, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100501', 'abnormal urogenital system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(522712, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131195', 'abnormally decreased number of Merkel cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522713, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100317', 'abnormal respiratory system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(522714, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102703', 'abnormal endoplasmic reticulum morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522715, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131720', 'abnormal mitotic spindle assembly', 0.45454545454545453, 5.835653092541957, 1.6286711109119212, 'HP:0011017', 'Abnormal cellular physiology'),
(522716, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127743', 'abnormally localised perivitelline space', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522717, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100902', 'abnormal spermatocyte', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(522718, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126548', 'abnormally localised centrosome', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522719, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131278', 'abnormally decreased number of keratin accumulating cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522720, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101220', 'abnormal centriole', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(522721, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103041', 'abnormal perivitelline space morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522722, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101022', 'abnormal blastomere V1.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522723, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100596', 'abnormal myocyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522724, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141498', 'abnormal axon microtubule bundle', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522725, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141315', 'abnormal anatomical region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522726, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136517', 'increased cell population proliferation in basal region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522727, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131383', 'abnormally decreased number of cementoblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522728, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103644', 'abnormally decreased number of cilium in the multiciliated cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522729, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107267', 'abnormal ventral side', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522730, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100422', 'abnormal notochord', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(522731, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100791', 'abnormal multiciliated cell precursor', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522732, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127196', 'abnormally localised electrically active cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522733, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131300', 'abnormally decreased number of alkali secreting cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522734, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131180', 'abnormally decreased number of cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522735, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139293', 'decreased cell population proliferation in organ part', 0.42857142857142855, 5.835653092541957, 1.5814531869511603, 'HP:0011017', 'Abnormal cellular physiology'),
(522736, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100557', 'abnormal prime meridian', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522737, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101451', 'abnormal dorsal lymph space', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(522738, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126214', 'absent microtubule', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522739, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139130', 'decreased cell population proliferation in interdigital region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522740, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101804', 'abnormal stem cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522741, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102181', 'abnormal mitotic cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522742, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136520', 'increased cell population proliferation in dorsal region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522743, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101212', 'abnormal glomeral mesenchyme', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(522744, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101503', 'abnormal organ cortex', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522745, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126495', 'abnormally localised keratin accumulating cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522746, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131136', 'abnormally increased number of multiciliated cell precursor', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522747, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100912', 'abnormal trabecula', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522748, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101302', 'abnormal subcortical cytoplasm', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(522749, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131165', 'abnormally increased number of cementoblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522750, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136516', 'increased cell population proliferation in axial region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522751, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100852', 'abnormal interdigital region', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(522752, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100610', 'abnormal appendage', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522753, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102423', 'abnormal multiciliated cell precursor morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522754, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131669', 'abnormal Roux spot', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(522755, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141265', 'abnormal escape behavior', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(522756, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103080', 'abnormal myelin accumulating cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522757, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141784', 'abnormal cellular hormone metabolic process', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(522758, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100397', 'abnormal ventral vegetal hemisphere blastomere', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(522759, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126983', 'abnormally localised primordial germ cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522760, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131131', 'abnormally increased number of absorptive cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522761, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126162', 'absent alkali secreting cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522762, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101921', 'abnormal chondroblast morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522763, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131090', 'abnormally increased number of oxygen accumulating cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522764, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107312', 'abnormal filopodium', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(522765, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107371', 'abnormal migrating myoblast morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522766, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100289', 'abnormal chondroblast', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522767, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127018', 'abnormally localised ciliated cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522768, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101480', 'abnormal stage V oocyte', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(522769, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0142030', 'abnormally localised desmosome', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522770, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127257', 'abnormally localised wedge region', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522771, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101083', 'abnormal T cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(522772, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135615', 'increased cell population proliferation in acellular anatomical structure', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522773, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100864', 'abnormal dorsolateral ascending neuron', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(522774, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141299', 'abnormal actin filament morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522775, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126472', 'abnormally localised secondary spermatogonium', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522776, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135160', 'increased cell population proliferation in embryo', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522777, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100511', 'abnormal stylopod', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(522778, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100888', 'abnormal microtubule', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(522779, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103414', 'abnormally increased number of vacuole in the spermatozoon', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522780, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138820', 'decreased cell population proliferation in anatomical line', 0.4411764705882353, 5.835653092541957, 1.6045413160604438, 'HP:0011017', 'Abnormal cellular physiology'),
(522781, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100481', 'abnormal anatomical line', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522782, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100416', 'abnormal ligament', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(522783, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141767', 'abnormal temperature homeostasis', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522784, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141892', 'abnormal inositol metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522785, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131066', 'abnormally increased number of myoblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522786, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100232', 'abnormal lymphatic system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(522787, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100915', 'abnormal dermal system', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522788, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101466', 'abnormal secondary myofiber', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522789, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101311', 'abnormal bottle cell', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(522790, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101569', 'abnormal activin-induced ectoderm', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522791, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101389', 'abnormal wedge region', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(522792, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125053', 'absent zygote', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522793, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136522', 'increased cell population proliferation in medial region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522794, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100423', 'abnormal process', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522795, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131308', 'abnormally decreased number of oxygen accumulating cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522796, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100176', 'abnormal stage VI oocyte', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(522797, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102347', 'abnormal ciliated cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522798, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101269', 'abnormal mesodermal cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(522799, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100006', 'abnormal anatomical structure', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522800, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100186', 'abnormal uveal tract', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522801, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126783', 'abnormally localised exocrine cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522802, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138837', 'decreased cell population proliferation in process', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522803, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100265', 'abnormal sensory epithelial cell', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(522804, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100581', 'abnormal immune system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(522805, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131685', 'abnormal cortical actin cytoskeleton', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(522806, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139618', 'decreased cell population proliferation in axial region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522807, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100025', 'abnormal oocyte', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(522808, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100108', 'abnormal cell part', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522809, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101016', 'abnormal egg', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522810, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100969', 'abnormal disaggregated/reaggregated ectoderm treated with activin', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522811, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102873', 'abnormal nucleate erythrocyte morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522812, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126671', 'abnormally localised zygote', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522813, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103099', 'abnormal alkali secreting cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522814, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141782', 'abnormal methylation', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522815, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127339', 'abnormally localised migrating myoblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522816, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131677', 'abnormal actin filament', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(522817, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127815', 'abnormally localised ciliated non-epidermal cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522818, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100531', 'abnormal proliferative region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522819, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101141', 'abnormal Keller explant', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522820, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101037', 'abnormal hatching gland cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(522821, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102994', 'abnormal vegetal cortex morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522822, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141789', 'abnormal hormone catabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522823, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138717', 'decreased cell population proliferation in acellular anatomical structure', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522824, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102852', 'abnormal centriole morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522825, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0130989', 'abnormally increased number of ciliated cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522826, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127168', 'abnormally localised chondroblast', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522827, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131134', 'abnormally increased number of barrier cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522828, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126737', 'abnormally localised mesenchymal stem cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522829, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102531', 'abnormal secondary spermatogonium morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522830, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102024', 'abnormal cilium morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522831, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127683', 'abnormally localised centromere', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522832, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100377', 'abnormal connective tissue', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(522833, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135735', 'increased cell population proliferation in process', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522834, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138584', 'decreased cell population proliferation in cell', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522835, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131691', 'abnormal molecular function', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(522836, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100337', 'abnormal zygote', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522837, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107287', 'abnormal afferent neuron', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(522838, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131550', 'abnormally localised adherens junction', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522839, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141898', 'abnormal maltose metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522840, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101168', 'abnormal circulating cell', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(522841, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101132', 'abnormal apoptotic cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522842, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100162', 'abnormal presumptive rhombomere', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522843, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100823', 'abnormal blood', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(522844, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100786', 'abnormal presumptive axial mesoderm', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522845, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100026', 'abnormal germ cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522846, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101079', 'abnormal blastomere D1.1.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522847, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135509', 'increased cell population proliferation in embryonic structure', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522848, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135483', 'increased cell population proliferation in organism subdivision', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522849, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100533', 'abnormal melanoblast', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522850, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136028', 'increased cell population proliferation in interdigital region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522851, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100062', 'abnormal anatomical space', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522852, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131292', 'abnormally decreased number of mucus secreting cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522853, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125785', 'absent mitotic spindle', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522854, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125454', 'absent myoblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522855, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100398', 'abnormal vegetal blastomere', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(522856, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107258', 'abnormal anatomical axis', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522857, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101157', 'abnormal female organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522858, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139423', 'decreased cell population proliferation in multicellular anatomical structure', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522859, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139626', 'decreased cell population proliferation in antero-ventral region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522860, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136519', 'increased cell population proliferation in posterior region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522861, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141788', 'abnormal hormone biosynthetic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522862, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100477', 'abnormal pericyte', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522863, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125976', 'absent centriole', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522864, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131346', 'abnormally decreased number of chondroblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522865, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100999', 'abnormal serous membrane', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522866, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101435', 'abnormal paracrine cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522867, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100688', 'abnormal adipose tissue', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(522868, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139619', 'decreased cell population proliferation in basal region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522869, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100034', 'abnormal blastomere V1.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522870, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125533', 'absent myelin accumulating cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522871, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131687', 'abnormal astral microtubule', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(522872, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131708', 'abnormal cilium disassembly', 0.5555555555555556, 5.835653092541957, 1.8005636605953823, 'HP:0011017', 'Abnormal cellular physiology'),
(522873, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131666', 'abnormal adherens junction', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(522874, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100458', 'abnormal autopod', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(522875, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101327', 'abnormal blastomere V1.2.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522876, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141264', 'abnormal schooling behavior', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(522877, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138818', 'decreased cell population proliferation in portion of organism substance', 0.4411764705882353, 5.835653092541957, 1.6045413160604438, 'HP:0011017', 'Abnormal cellular physiology'),
(522878, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100989', 'abnormal right blastomere', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(522879, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131654', 'abnormal neuron projection', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(522880, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101278', 'abnormal pigment cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522881, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100135', 'abnormal surface structure', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522882, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103005', 'abnormal oxygen accumulating cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522883, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100175', 'abnormal migrating neuroblast', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(522884, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138609', 'decreased cell population proliferation in tissue', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522885, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107323', 'abnormal thrombocyte', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522886, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100402', 'abnormal zeugopod', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(522887, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102588', 'abnormal centrosome morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522888, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103894', 'abnormally decreased number of spindle microtubule', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522889, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138822', 'decreased cell population proliferation in extraembryonic structure', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522890, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100449', 'abnormal lymphocyte', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(522891, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127338', 'abnormally localised mucus secreting cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522892, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100251', 'abnormal proteinaceous extracellular matrix', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522893, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101162', 'abnormal stromal cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(522894, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126600', 'abnormally localised progenitor cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522895, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100728', 'abnormal cell condensation', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522896, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136568', 'increased cell population proliferation in dorso-lateral region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522897, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101494', 'abnormal blastomere D1.2.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522898, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127533', 'abnormally localised spermatocyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522899, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139625', 'decreased cell population proliferation in antero-dorsal region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522900, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100032', 'abnormal nervous system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(522901, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107271', 'abnormal apical region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522902, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101264', 'abnormal mitotic spindle', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(522903, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102258', 'abnormal primordial germ cell morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522904, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107426', 'abnormal yolk platelet morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522905, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101515', 'abnormal neuromast mantle cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522906, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107270', 'abnormal proximal-distal axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522907, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100307', 'abnormal blastomere', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(522908, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100316', 'abnormal gamete', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522909, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100003', 'abnormal organism subdivision', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522910, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101497', 'abnormal ciliary axoneme', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(522911, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101373', 'abnormal oxygen accumulating cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522912, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141790', 'abnormal cellular metabolic process', 0.4583333333333333, 4.758907843651163, 1.4768771428276568, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522913, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100856', 'abnormal simple organ', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522914, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126159', 'absent apoptotic cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522915, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100549', 'abnormal mitotic cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522916, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0116091', 'abnormally increased variability of size of cell in endoderm', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(522917, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100907', 'abnormal cytoplasm', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(522918, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0130968', 'abnormally increased number of early embryonic cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522919, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138611', 'decreased cell population proliferation in embryonic structure', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522920, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0142064', 'abnormal desmosome morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522921, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103104', 'abnormal zygote cortex morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522922, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101576', 'abnormal blastomere V1.2.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522923, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102434', 'abnormal exocrine cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522924, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100493', 'abnormal liver and biliary system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(522925, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100427', 'abnormal olfactory system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(522926, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0133471', 'abnormally decreased number of cilium in the ciliated cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522927, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125384', 'absent ciliated cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522928, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127806', 'abnormally localised spermatid', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522929, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107260', 'abnormal anterior-posterior axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522930, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101587', 'abnormal hemangioblast', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(522931, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139127', 'decreased cell population proliferation in joint region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522932, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127476', 'abnormally localised nucleus', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522933, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131153', 'abnormally increased number of electrically active cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522934, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100282', 'abnormal pelvic girdle primordium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522935, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100415', 'abnormal secretory epithelial cell', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(522936, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101347', 'abnormal hindlimb region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522937, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100465', 'abnormal skeletal system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(522938, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141783', 'abnormal collagen metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522939, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101518', 'abnormal B cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(522940, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0115512', 'abnormally semi-erect whole organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522941, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100649', 'abnormal growth cone', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522942, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100172', 'abnormal stem cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522943, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131145', 'abnormally increased number of polar body', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522944, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102872', 'abnormal ciliated non-epidermal cell morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522945, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100372', 'abnormal hematological system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(522946, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131004', 'abnormally increased number of proepicardium', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522947, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135507', 'increased cell population proliferation in tissue', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522948, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100218', 'abnormal epithelial cell', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(522949, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100189', 'abnormal enteroendocrine cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(522950, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131089', 'abnormally increased number of mitotic cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522951, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0116434', 'abnormal biological process', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(522952, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131297', 'abnormally decreased number of melanoblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522953, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100509', 'abnormal germ plasm', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(522954, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100817', 'abnormal intersomitic neuron', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522955, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100843', 'abnormal fasciculated network of fibrils', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(522956, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0124864', 'absent germ cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522957, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107259', 'abnormal animal-vegetal axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522958, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101498', 'abnormal stage II oocyte', 0.5652173913043478, 3.6715585125471644, 1.440565418328227, 'UPHENO:0086172', 'abnormal cell'),
(522959, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127508', 'abnormally localised barrier epithelial cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522960, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141786', 'abnormal pigment metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522961, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135504', 'increased cell population proliferation in multi-tissue structure', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522962, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100437', 'abnormal proepicardium', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(522963, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101636', 'abnormal cell morphology', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(522964, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141776', 'abnormal metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522965, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100545', 'abnormal male organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522966, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100202', 'abnormal embryo', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522967, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135636', 'increased cell population proliferation in anatomical region', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(522968, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127337', 'abnormally localised oxygen accumulating cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522969, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131694', 'abnormal RNA polymerase II activity', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(522970, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136191', 'increased cell population proliferation in organ part', 0.42857142857142855, 5.835653092541957, 1.5814531869511603, 'HP:0011017', 'Abnormal cellular physiology'),
(522971, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127486', 'abnormally localised kinetochore', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522972, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101740', 'abnormal cell part morphology', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(522973, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100002', 'abnormal head', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(522974, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125868', 'absent cementoblast', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(522975, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136523', 'increased cell population proliferation in antero-dorsal region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522976, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100704', 'abnormal Merkel cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522977, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100151', 'abnormal primordium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522978, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100733', 'abnormal fibroblast', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(522979, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0135477', 'increased cell population proliferation in whole organism', 0.42857142857142855, 5.835653092541957, 1.5814531869511603, 'HP:0011017', 'Abnormal cellular physiology'),
(522980, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138233', 'decreased cell population proliferation in hindlimb region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(522981, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0142056', 'abnormal main body axis', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522982, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101133', 'abnormal motor neuron', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(522983, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101198', 'abnormal digestive enzyme secreting cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(522984, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101009', 'abnormal blastomere D1.1.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522985, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100887', 'abnormal right-dorsal blastomere', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(522986, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100960', 'abnormal postmigratory neural crest cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522987, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100394', 'abnormal marginal zone', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522988, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101333', 'abnormal barrier epithelial cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522989, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131723', 'abnormal pathway-restricted SMAD protein phosphorylation', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(522990, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127794', 'abnormally localised mitotic cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522991, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100993', 'abnormal ligament cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522992, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131247', 'abnormally decreased number of nucleate erythrocyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522993, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101406', 'abnormal cleavage furrow', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(522994, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100872', 'abnormal neuroendocrine cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(522995, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131352', 'abnormally decreased number of barrier cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(522996, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101094', 'abnormal blastomere V2.2.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(522997, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100691', 'abnormal keratin accumulating cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(522998, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101575', 'abnormal vitelline membrane', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(522999, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139500', 'decreased cell population proliferation in egg jelly', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(523000, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138585', 'decreased cell population proliferation in organism subdivision', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(523001, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100967', 'abnormal blastomere V2.1.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523002, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138262', 'decreased cell population proliferation in embryo', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(523003, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0115509', 'abnormally semi-viable whole organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523004, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100014', 'abnormal tissue', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523005, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131523', 'absent actin filament', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523006, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141772', 'abnormal water homeostasis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523007, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101658', 'abnormal germ cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(523008, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127343', 'abnormally localised filopodium', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(523009, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141738', 'abnormal carbon dioxide homeostasis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523010, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139628', 'decreased cell population proliferation in postero-ventral region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(523011, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131082', 'abnormally increased number of alkali secreting cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523012, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0133436', 'abnormal cilium morphology in the multiciliated cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523013, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141904', 'abnormal glucosamine metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(523014, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102336', 'abnormal Merkel cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(523015, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100084', 'abnormal anatomical group', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523016, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102526', 'abnormal nucleus morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523017, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107269', 'abnormal right side', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523018, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102869', 'abnormal mucus secreting cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(523019, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141911', 'abnormal ribose phosphate metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(523020, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100862', 'abnormal blastomere V1', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(523021, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100654', 'abnormal blastomere V2.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523022, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131032', 'abnormally increased number of acid secreting cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523023, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100702', 'abnormal glial cell', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(523024, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107303', 'abnormal migratory trunk neural crest cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523025, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100285', 'abnormal progenitor cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(523026, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100520', 'abnormal blastomere D1.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523027, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127391', 'abnormally localised lampbrush chromosome', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(523028, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139621', 'decreased cell population proliferation in posterior region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(523029, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100070', 'abnormal anatomical system', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523030, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141421', 'decreased cell population proliferation in tadpole', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(523031, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100894', 'abnormal nucleus', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(523032, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0133473', 'abnormally decreased number of cilium in the ciliated non-epidermal cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523033, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100417', 'abnormal dense regular connective tissue', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523034, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131202', 'abnormally decreased number of germ cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523035, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0115758', 'abnormally decreased mobility of melanoblast', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(523036, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141285', 'abnormal cortical actin cytoskeleton morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(523037, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125698', 'absent filopodium', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523038, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100546', 'abnormal whole organism', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523039, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102860', 'abnormal mesenchymal stem cell morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523040, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107285', 'abnormal flexural organ', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523041, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100569', 'abnormal motor axon', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523042, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141276', 'decreased surface breathing', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523043, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107273', 'abnormal basal region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523044, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102764', 'abnormal apoptotic cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(523045, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141771', 'abnormal urea homeostasis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523046, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101405', 'abnormal ring structure', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(523047, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101534', 'abnormal blastomere V2.1.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523048, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141497', 'abnormal lymphoblast', 0.5, 3.6715585125471644, 1.3549093166236559, 'UPHENO:0086172', 'abnormal cell'),
(523049, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101969', 'abnormal zygote morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(523050, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107265', 'abnormal posterior side', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523051, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141271', 'increased surface breathing', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523052, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141296', 'abnormal adherens junction morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523053, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100715', 'abnormal ciliated cell', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(523054, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126413', 'abnormally localised cell part', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(523055, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141511', 'abnormally localised nucleus in myoblast', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523056, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131531', 'absent cortical actin cytoskeleton', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523057, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100842', 'abnormal left-dorsal blastomere', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(523058, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127819', 'abnormally localised ciliary axoneme', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523059, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0115505', 'dead whole organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523060, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101411', 'abnormal marginal zone (sensu neural)', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523061, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141263', 'abnormal visually guided collision avoidance behavior', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523062, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141499', 'abnormal tadpole', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523063, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100395', 'abnormal blastomere D1.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523064, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0133443', 'abnormally increased number of cilium in the multiciliated cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523065, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103093', 'abnormal sperm entry point morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(523066, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101158', 'abnormal blastomere V2.2.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523067, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100859', 'abnormal blastomere V1.1.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523068, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126082', 'absent perivitelline space', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523069, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0142057', 'abnormal desmosome', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(523070, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127513', 'abnormally localised nucleate erythrocyte', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523071, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100643', 'abnormal thoracic region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523072, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131096', 'abnormally increased number of exocrine cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523073, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138738', 'decreased cell population proliferation in anatomical region', 0.4166666666666667, 5.835653092541957, 1.5593338712067029, 'HP:0011017', 'Abnormal cellular physiology'),
(523074, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141860', 'abnormal malate-aspartate shuttle', 0.4583333333333333, 4.758907843651163, 1.4768771428276568, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(523075, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101239', 'abnormal olfactory epithelial support cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(523076, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100332', 'abnormal germinal granule', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(523077, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101072', 'abnormal mitochondrial cloud', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(523078, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127217', 'abnormally localised cilium', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523079, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100060', 'abnormal regenerating tissue', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523080, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107288', 'abnormal larval alimentary system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523081, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100120', 'abnormal genital system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523082, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100900', 'abnormal angioblast', 0.52, 3.6715585125471644, 1.3817418089225373, 'UPHENO:0086172', 'abnormal cell'),
(523083, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138232', 'decreased cell population proliferation in forelimb region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(523084, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101345', 'abnormal ascending interneuron', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523085, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100164', 'abnormal neural nucleus', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523086, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102534', 'abnormal spermatocyte morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523087, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125854', 'absent barrier epithelial cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523088, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101657', 'abnormal oocyte morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523089, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100239', 'abnormal acellular anatomical structure', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523090, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141718', 'abnormal posterior notochord', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523091, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100384', 'abnormal amputated tissue', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523092, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100544', 'abnormal neuromast support cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523093, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102306', 'abnormal secondary oogonium morphology', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523094, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107284', 'abnormal migrating myoblast', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(523095, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100814', 'abnormal natural killer cell', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(523096, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0142023', 'absent desmosome', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523097, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102768', 'abnormal ooplasm morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523098, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0116494', 'absent biological process', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523099, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100638', 'abnormal polar body', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(523100, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138890', 'decreased cell population proliferation in intersomitic region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(523101, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139623', 'decreased cell population proliferation in ventral region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(523102, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102165', 'abnormal melanoblast morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(523103, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100676', 'abnormal blastomere D2.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523104, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101481', 'abnormal skeletal muscle satellite cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523105, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101514', 'abnormal dendrite', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523106, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102109', 'abnormal pericyte morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(523107, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107264', 'abnormal anterior side', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523108, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107266', 'abnormal dorsal side', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523109, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125824', 'absent nucleus', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523110, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125577', 'absent cilium', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523111, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125692', 'absent oxygen accumulating cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523112, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139670', 'decreased cell population proliferation in dorso-lateral region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(523113, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100653', 'abnormal myoblast', 0.6190476190476191, 3.6715585125471644, 1.5076039119696991, 'UPHENO:0086172', 'abnormal cell'),
(523114, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102958', 'abnormal cementoblast morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(523115, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0124984', 'absent progenitor cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523116, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101240', 'abnormal ciliated non-epidermal cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(523117, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100965', 'abnormal blastomere V2.2', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523118, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125779', 'absent endoplasmic reticulum', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523119, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141794', 'abnormal prosthetic group metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(523120, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126314', 'absent absorptive cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523121, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139617', 'decreased cell population proliferation in apical region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(523122, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102704', 'abnormal mitochondrial cloud morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523123, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131205', 'abnormally decreased number of ciliated cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523124, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100225', 'abnormal endocrine system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523125, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100010', 'abnormal multicellular anatomical structure', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523126, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101519', 'abnormal hypobranchial placode', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523127, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100274', 'abnormal sensory system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523128, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127703', 'abnormally localised morula cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523129, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107276', 'abnormal dorsal region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523130, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100781', 'abnormal presumptive ectoderm', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523131, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126133', 'absent mitotic cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523132, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127979', 'abnormally localised absorptive cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523133, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100258', 'abnormal organ part', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523134, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101109', 'abnormal egg cell-free extract', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523135, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100081', 'abnormal anatomical entity in vitro', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523136, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100784', 'abnormal left blastomere', 0.5416666666666666, 3.6715585125471644, 1.4102343283876786, 'UPHENO:0086172', 'abnormal cell'),
(523137, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102896', 'abnormal mitotic spindle morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523138, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100035', 'abnormal ventral animal hemisphere blastomere', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(523139, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141907', 'abnormal putrescine metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(523140, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131204', 'abnormally decreased number of pericyte', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523141, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101570', 'abnormal forelimb region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523142, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126630', 'abnormally localised early embryonic cell', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(523143, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0136526', 'increased cell population proliferation in postero-ventral region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(523144, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125724', 'absent polar body', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523145, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101374', 'abnormal migratory neural crest cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523146, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100104', 'abnormal embryonic structure', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523147, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141792', 'abnormal small molecule metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(523148, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0103129', 'abnormal ciliary axoneme morphology', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523149, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101040', 'abnormal axial mesoderm', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523150, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100640', 'abnormal notochordal sheath', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523151, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141743', 'abnormal chemical homeostasis within a tissue', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523152, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127160', 'abnormally localised acid secreting cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523153, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100913', 'abnormal Brachets cleft', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523154, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0139624', 'decreased cell population proliferation in medial region', 0.40540540540540543, 5.835653092541957, 1.5381174557839463, 'HP:0011017', 'Abnormal cellular physiology'),
(523155, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0124934', 'absent centrosome', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523156, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0138576', 'decreased cell population proliferation in anatomical structure', 0.4411764705882353, 5.835653092541957, 1.6045413160604438, 'HP:0011017', 'Abnormal cellular physiology'),
(523157, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141777', 'abnormal catabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(523158, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101500', 'abnormal endodermal cell', 0.48148148148148145, 3.6715585125471644, 1.3295816755533123, 'UPHENO:0086172', 'abnormal cell'),
(523159, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100899', 'abnormal secondary spermatogonium', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(523160, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100642', 'abnormal gustatory system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523161, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100713', 'abnormal monociliated cell', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523162, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131328', 'abnormally decreased number of paracrine cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523163, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100336', 'abnormal interneuron', 0.4642857142857143, 3.6715585125471644, 1.305623286610558, 'UPHENO:0086172', 'abnormal cell'),
(523164, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100991', 'abnormal iliac process primordium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523165, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102929', 'abnormal barrier cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(523166, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0102323', 'abnormal keratin accumulating cell morphology', 0.43333333333333335, 3.6715585125471644, 1.2613519289914445, 'UPHENO:0086172', 'abnormal cell'),
(523167, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125859', 'absent nucleate erythrocyte', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523168, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141277', 'abnormal actin cytoskeleton morphology', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523169, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100570', 'abnormal axon', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523170, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141748', 'abnormal gas homeostasis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523171, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131667', 'abnormal actin cytoskeleton', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(523172, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0125394', 'absent multiciliated cell precursor', 0.41935483870967744, 3.6715585125471644, 1.240840774572773, 'UPHENO:0086172', 'abnormal cell'),
(523173, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101228', 'abnormal mesenchymal stem cell', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(523174, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101192', 'abnormal blastomere D2.1', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523175, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141797', 'abnormal hydrogen metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(523176, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0131371', 'abnormally decreased number of electrically active cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523177, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101061', 'abnormal plasma membrane', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(523178, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101513', 'abnormal basal body', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(523179, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0127653', 'abnormally localised Merkel cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523180, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0133438', 'abnormal cilium morphology in the ciliated non-epidermal cell', 0.40625, 3.6715585125471644, 1.221298753672616, 'UPHENO:0086172', 'abnormal cell'),
(523181, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0100429', 'abnormal spermatid', 0.5909090909090909, 3.6715585125471644, 1.4729417174039097, 'UPHENO:0086172', 'abnormal cell'),
(523182, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0107268', 'abnormal left side', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523183, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0141796', 'abnormal demethylation', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(523184, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0101485', 'abnormal descending interneuron', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523185, 'HP:0004371', 'Abnormality of glycosaminoglycan metabolism', 'XPO:0126738', 'abnormally localised paracrine cell', 0.4482758620689655, 3.6715585125471644, 1.2829150624062098, 'UPHENO:0086172', 'abnormal cell'),
(523186, 'HP:0410291', 'Negativism', 'XPO:0100032', 'abnormal nervous system', 0.40625, 3.94131651835137, 1.2653694462805098, 'UPHENO:0004523', 'abnormal nervous system'),
(523187, 'HP:5200241', 'Recurrent maladaptive behavior', 'XPO:0100032', 'abnormal nervous system', 0.40625, 3.94131651835137, 1.2653694462805098, 'UPHENO:0004523', 'abnormal nervous system'),
(523188, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0131554', 'abnormally localised maxillary nerve', 0.4090909090909091, 8.429051634704384, 1.8569459862945477, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523189, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0102366', 'abnormal lateral line system morphology', 0.42, 7.318748312764234, 1.753246785641137, 'HP:0000759', 'Abnormal peripheral nervous system morphology'),
(523190, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0100167', 'abnormal nerve', 0.4782608695652174, 8.429051634704384, 2.007806157083855, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523191, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0126818', 'abnormally localised cranial nerve', 0.421875, 8.429051634704384, 1.8857375634989384, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523192, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0126417', 'abnormally localised nerve', 0.4107142857142857, 8.429051634704384, 1.8606267549931779, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523193, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0101600', 'abnormal Schwann cell', 0.4230769230769231, 8.429051634704384, 1.8884218887916013, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523194, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0101421', 'abnormal oculomotor nerve', 0.49056603773584906, 8.429051634704384, 2.033471529750985, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523195, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0101335', 'abnormal vagus nerve', 0.4727272727272727, 8.429051634704384, 1.9961569554900145, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523196, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0131679', 'abnormal frontal nerve', 0.48148148148148145, 8.429051634704384, 2.0145551043745042, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523197, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0131572', 'abnormally localised mandibular nerve', 0.4090909090909091, 8.429051634704384, 1.8569459862945477, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523198, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0100223', 'abnormal facial nerve', 0.5409836065573771, 12.30515924801628, 2.580094848887286, 'UPHENO:0078730', 'abnormality of cranial nerve physiology'),
(523199, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0101952', 'abnormal lateral line morphology', 0.40384615384615385, 7.318748312764234, 1.7191999177169197, 'HP:0000759', 'Abnormal peripheral nervous system morphology'),
(523200, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0131536', 'abnormally localised cephalic nerve', 0.43548387096774194, 8.429051634704384, 1.9159112804271596, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523201, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0101118', 'abnormal trochlear nerve', 0.49056603773584906, 8.429051634704384, 2.033471529750985, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523202, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0101458', 'abnormal vestibulocochlear ganglion', 0.4126984126984127, 8.429051634704384, 1.8651156077293065, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523203, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0101204', 'abnormal peripheral nerve', 0.4782608695652174, 8.429051634704384, 2.007806157083855, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523204, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0101030', 'abnormal spinal nerve', 0.4583333333333333, 8.429051634704384, 1.9655318192725455, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523205, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0101746', 'abnormal peripheral nervous system morphology', 0.4375, 7.318748312764234, 1.7894000074981424, 'HP:0000759', 'Abnormal peripheral nervous system morphology'),
(523206, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0101510', 'abnormal optic nerve', 0.40625, 8.429051634704384, 1.8504870241638163, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523207, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0131563', 'abnormally localised frontal nerve', 0.4090909090909091, 8.429051634704384, 1.8569459862945477, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523208, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0101596', 'abnormal accessory nerve', 0.4406779661016949, 8.429051634704384, 1.9273031236802618, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523209, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0100849', 'abnormal abducens nerve', 0.4406779661016949, 8.429051634704384, 1.9273031236802618, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523210, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0131670', 'abnormal maxillary nerve', 0.48148148148148145, 8.429051634704384, 2.0145551043745042, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523211, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0131555', 'abnormally localised nasociliary nerve', 0.4090909090909091, 8.429051634704384, 1.8569459862945477, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523212, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0131688', 'abnormal mandibular nerve', 0.48148148148148145, 8.429051634704384, 2.0145551043745042, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523213, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0127813', 'abnormally localised peripheral nerve', 0.4107142857142857, 8.429051634704384, 1.8606267549931779, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523214, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0100110', 'abnormal trigeminal nerve', 0.49056603773584906, 8.429051634704384, 2.033471529750985, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523215, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0101185', 'abnormal vestibulocochlear nerve', 0.4262295081967213, 8.429051634704384, 1.895444679441956, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523216, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0100635', 'abnormal sympathetic chain', 0.44, 8.429051634704384, 1.925820012168824, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523217, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0126817', 'abnormally localised trigeminal nerve', 0.4090909090909091, 8.429051634704384, 1.8569459862945477, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523218, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0131652', 'abnormal cephalic nerve', 0.5098039215686274, 8.429051634704384, 2.0729601005510805, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523219, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0126252', 'absent facial nerve', 0.4177215189873418, 12.30515924801628, 2.267185438481488, 'UPHENO:0078730', 'abnormality of cranial nerve physiology'),
(523220, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0101427', 'abnormal ampullary nerve', 0.41935483870967744, 8.429051634704384, 1.8800966966480739, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523221, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0101541', 'abnormal olfactory nerve', 0.4727272727272727, 8.429051634704384, 1.9961569554900145, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523222, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0100111', 'abnormal cranial nerve', 0.5, 8.429051634704384, 2.0529310308318185, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523223, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0131498', 'absent cephalic nerve', 0.4090909090909091, 8.429051634704384, 1.8569459862945477, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523224, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0131671', 'abnormal nasociliary nerve', 0.48148148148148145, 8.429051634704384, 2.0145551043745042, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523225, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0127421', 'abnormally localised oculomotor nerve', 0.4090909090909091, 8.429051634704384, 1.8569459862945477, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523226, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0141281', 'abnormal cephalic nerve morphology', 0.4090909090909091, 8.429051634704384, 1.8569459862945477, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523227, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0127916', 'abnormally localised facial nerve', 0.44, 12.30515924801628, 2.3268584119209237, 'UPHENO:0078730', 'abnormality of cranial nerve physiology'),
(523228, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0127971', 'abnormally localised trochlear nerve', 0.4090909090909091, 8.429051634704384, 1.8569459862945477, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523229, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0100739', 'abnormal hypoglossal nerve', 0.4090909090909091, 8.429051634704384, 1.8569459862945477, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523230, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0101855', 'abnormal facial nerve morphology', 0.4230769230769231, 12.30515924801628, 2.281672393798521, 'UPHENO:0078730', 'abnormality of cranial nerve physiology'),
(523231, 'HP:0410262', 'Lower cranial nerve dysfunction', 'XPO:0101207', 'abnormal glossopharyngeal nerve', 0.4727272727272727, 8.429051634704384, 1.9961569554900145, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523232, 'HP:0011219', 'Short face', 'XPO:0128440', 'decreased size of the Jacobsons organ', 0.4153846153846154, 5.788671267106304, 1.5506530843083268, 'UPHENO:0087472', 'abnormal face morphology'),
(523233, 'HP:0011219', 'Short face', 'XPO:0103561', 'decreased length of anterior-posterior axis', 0.41304347826086957, 8.382327108538739, 1.8607164063422503, 'UPHENO:0031839', 'decreased length of anatomical entity in independent continuant'),
(523234, 'HP:0011219', 'Short face', 'XPO:0115526', 'abnormally incomplete structure of head', 0.4375, 4.5318002188002176, 1.4080705222839853, 'UPHENO:0087907', 'abnormal head morphology'),
(523235, 'HP:0011219', 'Short face', 'XPO:0141835', 'edematous head', 0.42857142857142855, 4.5318002188002176, 1.3936283915633758, 'UPHENO:0087907', 'abnormal head morphology'),
(523236, 'HP:0011219', 'Short face', 'XPO:0102804', 'abnormal pharyngeal pouch morphology', 0.42, 4.5318002188002176, 1.3796217205799897, 'UPHENO:0087907', 'abnormal head morphology'),
(523237, 'HP:0011219', 'Short face', 'XPO:0100420', 'abnormal choana', 0.43636363636363634, 5.788671267106304, 1.589328677092377, 'UPHENO:0087472', 'abnormal face morphology'),
(523238, 'HP:0011219', 'Short face', 'XPO:0101634', 'abnormal head morphology', 0.44680851063829785, 4.5318002188002176, 1.422971154406314, 'UPHENO:0087907', 'abnormal head morphology'),
(523239, 'HP:0011219', 'Short face', 'XPO:0140223', 'abnormally necrotic head region', 0.40384615384615385, 4.5318002188002176, 1.3528303989641963, 'UPHENO:0087907', 'abnormal head morphology'),
(523240, 'HP:0011219', 'Short face', 'XPO:0128795', 'decreased size of the pharyngeal pouch', 0.4444444444444444, 5.653868323764771, 1.5851909557266834, 'UPHENO:0012541', 'decreased size of the anatomical entity in the independent continuant'),
(523241, 'HP:0011219', 'Short face', 'XPO:0102259', 'abnormal pharyngeal region morphology', 0.45652173913043476, 4.5318002188002176, 1.4383550734357495, 'UPHENO:0087907', 'abnormal head morphology'),
(523242, 'HP:0011219', 'Short face', 'XPO:0142059', 'abnormal nasal region morphology', 0.4375, 4.5318002188002176, 1.4080705222839853, 'UPHENO:0087907', 'abnormal head morphology'),
(523243, 'HP:0011219', 'Short face', 'XPO:0103707', 'increased pigmentation in the head', 0.42, 4.5318002188002176, 1.3796217205799897, 'UPHENO:0087907', 'abnormal head morphology'),
(523244, 'HP:0011219', 'Short face', 'XPO:0131638', 'increased size of the intercanthal region', 0.41509433962264153, 4.6864066944795475, 1.3947404389520346, 'UPHENO:0075195', 'abnormal size of anatomical entity'),
(523245, 'HP:0011219', 'Short face', 'XPO:0128568', 'decreased size of the optic disc', 0.40298507462686567, 5.788671267106304, 1.5273336644509696, 'UPHENO:0087472', 'abnormal face morphology'),
(523246, 'HP:0011219', 'Short face', 'XPO:0141839', 'edematous pharyngeal region', 0.4375, 4.5318002188002176, 1.4080705222839853, 'UPHENO:0087907', 'abnormal head morphology'),
(523247, 'HP:0011219', 'Short face', 'XPO:0103101', 'abnormal medial nasal prominence morphology', 0.42, 4.5318002188002176, 1.3796217205799897, 'UPHENO:0087907', 'abnormal head morphology'),
(523248, 'HP:0011219', 'Short face', 'XPO:0129311', 'decreased size of the lateral nasal prominence', 0.4528301886792453, 5.653868323764771, 1.6000757044021416, 'UPHENO:0012541', 'decreased size of the anatomical entity in the independent continuant'),
(523249, 'HP:0011219', 'Short face', 'XPO:0131600', 'decreased size of the intercanthal region', 0.47058823529411764, 5.653868323764771, 1.6311480365269653, 'UPHENO:0012541', 'decreased size of the anatomical entity in the independent continuant'),
(523250, 'HP:0011219', 'Short face', 'XPO:0140914', 'abnormally necrotic intercanthal region', 0.40384615384615385, 4.5318002188002176, 1.3528303989641963, 'UPHENO:0087907', 'abnormal head morphology'),
(523251, 'HP:0011219', 'Short face', 'XPO:0130062', 'increased size of the head region', 0.41509433962264153, 4.6864066944795475, 1.3947404389520346, 'UPHENO:0075195', 'abnormal size of anatomical entity'),
(523252, 'HP:0011219', 'Short face', 'XPO:0103739', 'increased size of the pharyngeal region', 0.44, 4.6864066944795475, 1.4359731702128007, 'UPHENO:0075195', 'abnormal size of anatomical entity'),
(523253, 'HP:0011219', 'Short face', 'XPO:0128841', 'decreased size of the craniofacial region', 0.4444444444444444, 5.653868323764771, 1.5851909557266834, 'UPHENO:0012541', 'decreased size of the anatomical entity in the independent continuant'),
(523254, 'HP:0011219', 'Short face', 'XPO:0128817', 'decreased size of the hatching gland primordium', 0.42857142857142855, 5.653868323764771, 1.5566266169093397, 'UPHENO:0012541', 'decreased size of the anatomical entity in the independent continuant'),
(523255, 'HP:0011219', 'Short face', 'XPO:0102966', 'abnormal olfactory pit morphology', 0.41379310344827586, 5.788671267106304, 1.5476796336638217, 'UPHENO:0087472', 'abnormal face morphology'),
(523256, 'HP:0011219', 'Short face', 'XPO:0102572', 'abnormal hatching gland primordium morphology', 0.40384615384615385, 4.5318002188002176, 1.3528303989641963, 'UPHENO:0087907', 'abnormal head morphology'),
(523257, 'HP:0011219', 'Short face', 'XPO:0103582', 'decreased length of dorsal-ventral axis', 0.4222222222222222, 8.382327108538739, 1.881277432799533, 'UPHENO:0031839', 'decreased length of anatomical entity in independent continuant'),
(523258, 'HP:0011219', 'Short face', 'XPO:0141298', 'abnormal intercanthal region morphology', 0.42857142857142855, 4.5318002188002176, 1.3936283915633758, 'UPHENO:0087907', 'abnormal head morphology'),
(523259, 'HP:0011219', 'Short face', 'XPO:0102538', 'abnormal lateral nasal prominence morphology', 0.42, 4.5318002188002176, 1.3796217205799897, 'UPHENO:0087907', 'abnormal head morphology'),
(523260, 'HP:0011219', 'Short face', 'XPO:0102734', 'abnormal craniofacial region morphology', 0.42, 4.5318002188002176, 1.3796217205799897, 'UPHENO:0087907', 'abnormal head morphology'),
(523261, 'HP:0011219', 'Short face', 'XPO:0129164', 'decreased size of the medial nasal prominence', 0.4528301886792453, 5.653868323764771, 1.6000757044021416, 'UPHENO:0012541', 'decreased size of the anatomical entity in the independent continuant'),
(523262, 'HP:0011219', 'Short face', 'XPO:0141339', 'decreased pigmentation in the head', 0.42, 4.5318002188002176, 1.3796217205799897, 'UPHENO:0087907', 'abnormal head morphology'),
(523263, 'HP:0011219', 'Short face', 'XPO:0103342', 'decreased size of the head', 0.4528301886792453, 5.653868323764771, 1.6000757044021416, 'UPHENO:0012541', 'decreased size of the anatomical entity in the independent continuant'),
(523264, 'HP:0011219', 'Short face', 'XPO:0139715', 'abnormally necrotic head', 0.40384615384615385, 4.5318002188002176, 1.3528303989641963, 'UPHENO:0087907', 'abnormal head morphology'),
(523265, 'HP:0011219', 'Short face', 'XPO:0128599', 'decreased size of the olfactory pit', 0.45, 5.788671267106304, 1.613970901285967, 'UPHENO:0087472', 'abnormal face morphology'),
(523266, 'HP:0011219', 'Short face', 'XPO:0102082', 'abnormal circumpharyngeal ridge morphology', 0.4117647058823529, 4.5318002188002176, 1.3660290568695288, 'UPHENO:0087907', 'abnormal head morphology'),
(523267, 'HP:0011219', 'Short face', 'XPO:0103358', 'decreased size of the pharyngeal region', 0.5, 5.653868323764771, 1.681348911404883, 'UPHENO:0012541', 'decreased size of the anatomical entity in the independent continuant'),
(523268, 'HP:0011219', 'Short face', 'XPO:0130079', 'increased size of the olfactory pit', 0.4032258064516129, 5.788671267106304, 1.5277897891929437, 'UPHENO:0087472', 'abnormal face morphology'),
(523269, 'HP:0011219', 'Short face', 'XPO:0129227', 'decreased size of the circumpharyngeal ridge', 0.4444444444444444, 5.653868323764771, 1.5851909557266834, 'UPHENO:0012541', 'decreased size of the anatomical entity in the independent continuant'),
(523270, 'HP:0011219', 'Short face', 'XPO:0128582', 'decreased size of the head region', 0.47058823529411764, 5.653868323764771, 1.6311480365269653, 'UPHENO:0012541', 'decreased size of the anatomical entity in the independent continuant'),
(523271, 'HP:0011219', 'Short face', 'XPO:0140335', 'abnormally necrotic pharyngeal region', 0.42857142857142855, 4.5318002188002176, 1.3936283915633758, 'UPHENO:0087907', 'abnormal head morphology'),
(523272, 'HP:0011219', 'Short face', 'XPO:0103826', 'decreased width of the craniofacial region', 0.42105263157894735, 5.653868323764771, 1.5429115776096853, 'UPHENO:0012541', 'decreased size of the anatomical entity in the independent continuant'),
(523273, 'HP:0011219', 'Short face', 'XPO:0142038', 'decreased size of the nasal region', 0.4444444444444444, 5.653868323764771, 1.5851909557266834, 'UPHENO:0012541', 'decreased size of the anatomical entity in the independent continuant'),
(523274, 'HP:0011219', 'Short face', 'XPO:0101483', 'abnormal nostril', 0.4528301886792453, 5.788671267106304, 1.6190383263177786, 'UPHENO:0087472', 'abnormal face morphology'),
(523275, 'HP:0011219', 'Short face', 'XPO:0103827', 'decreased width of the head', 0.42105263157894735, 5.653868323764771, 1.5429115776096853, 'UPHENO:0012541', 'decreased size of the anatomical entity in the independent continuant'),
(523276, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0140914', 'abnormally necrotic intercanthal region', 0.42, 4.5318002188002176, 1.3796217205799897, 'UPHENO:0087907', 'abnormal head morphology'),
(523277, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0103739', 'increased size of the pharyngeal region', 0.42857142857142855, 4.5318002188002176, 1.3936283915633758, 'UPHENO:0087907', 'abnormal head morphology'),
(523278, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0102804', 'abnormal pharyngeal pouch morphology', 0.4375, 4.5318002188002176, 1.4080705222839853, 'UPHENO:0087907', 'abnormal head morphology'),
(523279, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0101634', 'abnormal head morphology', 0.4666666666666667, 4.5318002188002176, 1.4542489821577214, 'UPHENO:0087907', 'abnormal head morphology'),
(523280, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0102224', 'abnormal auditory apparatus morphology', 0.43859649122807015, 7.26295268789559, 1.7847984661766398, 'UPHENO:0076730', 'abnormal ear morphology'),
(523281, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0102082', 'abnormal circumpharyngeal ridge morphology', 0.42857142857142855, 4.5318002188002176, 1.3936283915633758, 'UPHENO:0087907', 'abnormal head morphology'),
(523282, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0102168', 'abnormal inner ear morphology', 0.4032258064516129, 7.26295268789559, 1.711318192153817, 'UPHENO:0076730', 'abnormal ear morphology'),
(523283, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0141298', 'abnormal intercanthal region morphology', 0.44680851063829785, 4.5318002188002176, 1.422971154406314, 'UPHENO:0087907', 'abnormal head morphology'),
(523284, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0140335', 'abnormally necrotic pharyngeal region', 0.44680851063829785, 4.5318002188002176, 1.422971154406314, 'UPHENO:0087907', 'abnormal head morphology'),
(523285, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0102482', 'abnormal auditory tube morphology', 0.4166666666666667, 7.26295268789559, 1.7396063596754188, 'UPHENO:0076730', 'abnormal ear morphology'),
(523286, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0102637', 'abnormal middle ear morphology', 0.4032258064516129, 7.26295268789559, 1.711318192153817, 'UPHENO:0076730', 'abnormal ear morphology'),
(523287, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0140223', 'abnormally necrotic head region', 0.42, 4.5318002188002176, 1.3796217205799897, 'UPHENO:0087907', 'abnormal head morphology'),
(523288, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0131638', 'increased size of the intercanthal region', 0.40384615384615385, 4.5318002188002176, 1.3528303989641963, 'UPHENO:0087907', 'abnormal head morphology'),
(523289, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0140017', 'abnormally necrotic lateral nasal prominence', 0.40384615384615385, 4.5318002188002176, 1.3528303989641963, 'UPHENO:0087907', 'abnormal head morphology'),
(523290, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0115526', 'abnormally incomplete structure of head', 0.45652173913043476, 4.5318002188002176, 1.4383550734357495, 'UPHENO:0087907', 'abnormal head morphology'),
(523291, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0139715', 'abnormally necrotic head', 0.42, 4.5318002188002176, 1.3796217205799897, 'UPHENO:0087907', 'abnormal head morphology'),
(523292, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0142059', 'abnormal nasal region morphology', 0.45652173913043476, 4.5318002188002176, 1.4383550734357495, 'UPHENO:0087907', 'abnormal head morphology'),
(523293, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0131600', 'decreased size of the intercanthal region', 0.40384615384615385, 4.5318002188002176, 1.3528303989641963, 'UPHENO:0087907', 'abnormal head morphology'),
(523294, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0101367', 'abnormal vestibular apparatus', 0.4074074074074074, 7.26295268789559, 1.7201688070355778, 'UPHENO:0076730', 'abnormal ear morphology'),
(523295, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0102538', 'abnormal lateral nasal prominence morphology', 0.4375, 4.5318002188002176, 1.4080705222839853, 'UPHENO:0087907', 'abnormal head morphology'),
(523296, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0100536', 'abnormal inner ear', 0.41509433962264153, 7.26295268789559, 1.7363209811819096, 'UPHENO:0076730', 'abnormal ear morphology'),
(523297, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0103101', 'abnormal medial nasal prominence morphology', 0.4375, 4.5318002188002176, 1.4080705222839853, 'UPHENO:0087907', 'abnormal head morphology'),
(523298, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0140668', 'abnormally necrotic medial nasal prominence', 0.40384615384615385, 4.5318002188002176, 1.3528303989641963, 'UPHENO:0087907', 'abnormal head morphology'),
(523299, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0128582', 'decreased size of the head region', 0.40384615384615385, 4.5318002188002176, 1.3528303989641963, 'UPHENO:0087907', 'abnormal head morphology'),
(523300, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0141631', 'neoplastic auditory apparatus', 0.4166666666666667, 7.26295268789559, 1.7396063596754188, 'UPHENO:0076730', 'abnormal ear morphology'),
(523301, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0141839', 'edematous pharyngeal region', 0.45652173913043476, 4.5318002188002176, 1.4383550734357495, 'UPHENO:0087907', 'abnormal head morphology'),
(523302, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0126939', 'abnormally localised auditory apparatus', 0.5409836065573771, 10.484129389061598, 2.381541964465194, 'UPHENO:0005986', 'abnormal shape of external ear'),
(523303, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0103707', 'increased pigmentation in the head', 0.4375, 4.5318002188002176, 1.4080705222839853, 'UPHENO:0087907', 'abnormal head morphology'),
(523304, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0141339', 'decreased pigmentation in the head', 0.4375, 4.5318002188002176, 1.4080705222839853, 'UPHENO:0087907', 'abnormal head morphology'),
(523305, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0130062', 'increased size of the head region', 0.40384615384615385, 4.5318002188002176, 1.3528303989641963, 'UPHENO:0087907', 'abnormal head morphology'),
(523306, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0102572', 'abnormal hatching gland primordium morphology', 0.42, 4.5318002188002176, 1.3796217205799897, 'UPHENO:0087907', 'abnormal head morphology'),
(523307, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0101005', 'abnormal middle ear', 0.41509433962264153, 7.26295268789559, 1.7363209811819096, 'UPHENO:0076730', 'abnormal ear morphology'),
(523308, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0102734', 'abnormal craniofacial region morphology', 0.4375, 4.5318002188002176, 1.4080705222839853, 'UPHENO:0087907', 'abnormal head morphology'),
(523309, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0141835', 'edematous head', 0.44680851063829785, 4.5318002188002176, 1.422971154406314, 'UPHENO:0087907', 'abnormal head morphology'),
(523310, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0102259', 'abnormal pharyngeal region morphology', 0.4772727272727273, 4.5318002188002176, 1.4706816956370683, 'UPHENO:0087907', 'abnormal head morphology'),
(523311, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0100850', 'abnormal auditory tube', 0.4230769230769231, 7.26295268789559, 1.7529368715524625, 'UPHENO:0076730', 'abnormal ear morphology'),
(523312, 'HP:0010723', 'Cystic lesions of the pinnae', 'XPO:0103358', 'decreased size of the pharyngeal region', 0.42857142857142855, 4.5318002188002176, 1.3936283915633758, 'UPHENO:0087907', 'abnormal head morphology'),
(523313, 'HP:0003180', 'Flat acetabular roof', 'XPO:0100178', 'abnormal digit', 0.41935483870967744, 5.802924133159483, 1.5599629206829213, 'UPHENO:0076727', 'abnormal limb bone morphology'),
(523314, 'HP:0031732', 'Increased basal tear production', 'XPO:0100564', 'abnormal central retina', 0.4117647058823529, 6.02624522851634, 1.5752444553449358, 'HP:0000478', 'Abnormality of the eye'),
(523315, 'HP:0031732', 'Increased basal tear production', 'XPO:0100485', 'abnormal retina', 0.42, 6.02624522851634, 1.590918915588366, 'HP:0000478', 'Abnormality of the eye'),
(523316, 'HP:0031732', 'Increased basal tear production', 'XPO:0101390', 'abnormal ciliary body', 0.40384615384615385, 6.02624522851634, 1.560024345217106, 'HP:0000478', 'Abnormality of the eye'),
(523317, 'HP:0031732', 'Increased basal tear production', 'XPO:0101289', 'abnormal orbital region', 0.40425531914893614, 5.757493499662858, 1.5256137690136826, 'HP:0000315', 'Abnormality of the orbital region'),
(523318, 'HP:0031732', 'Increased basal tear production', 'XPO:0101230', 'abnormal iris', 0.40384615384615385, 6.02624522851634, 1.560024345217106, 'HP:0000478', 'Abnormality of the eye'),
(523319, 'HP:0031732', 'Increased basal tear production', 'XPO:0142052', 'abnormal nasal region', 0.40540540540540543, 3.868794716113063, 1.2523698696136485, 'UPHENO:0002844', 'abnormal head'),
(523320, 'HP:0031732', 'Increased basal tear production', 'XPO:0100002', 'abnormal head', 0.40540540540540543, 3.868794716113063, 1.2523698696136485, 'UPHENO:0002844', 'abnormal head'),
(523321, 'HP:0031732', 'Increased basal tear production', 'XPO:0101416', 'abnormal cornea', 0.4117647058823529, 6.02624522851634, 1.5752444553449358, 'HP:0000478', 'Abnormality of the eye'),
(523322, 'HP:0031732', 'Increased basal tear production', 'XPO:0101173', 'abnormal retinal layer', 0.45652173913043476, 6.02624522851634, 1.6586476274811248, 'HP:0000478', 'Abnormality of the eye'),
(523323, 'HP:0031732', 'Increased basal tear production', 'XPO:0101578', 'abnormal pupil', 0.4117647058823529, 6.02624522851634, 1.5752444553449358, 'HP:0000478', 'Abnormality of the eye'),
(523324, 'HP:0031732', 'Increased basal tear production', 'XPO:0100918', 'abnormal lens', 0.42, 6.02624522851634, 1.590918915588366, 'HP:0000478', 'Abnormality of the eye'),
(523325, 'HP:0031732', 'Increased basal tear production', 'XPO:0100844', 'abnormal lens transitional zone', 0.40384615384615385, 6.02624522851634, 1.560024345217106, 'HP:0000478', 'Abnormality of the eye'),
(523326, 'HP:0031732', 'Increased basal tear production', 'XPO:0100881', 'abnormal sclera', 0.42, 6.02624522851634, 1.590918915588366, 'HP:0000478', 'Abnormality of the eye'),
(523327, 'HP:0031732', 'Increased basal tear production', 'XPO:0101554', 'abnormal peripheral retina', 0.4117647058823529, 6.02624522851634, 1.5752444553449358, 'HP:0000478', 'Abnormality of the eye'),
(523328, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0103059', 'abnormal ampullary nerve morphology', 0.40789473684210525, 9.57905464648184, 1.9766754853093251, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523329, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0131671', 'abnormal nasociliary nerve', 0.4482758620689655, 8.429051634704384, 1.9438468015692314, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523330, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0102750', 'abnormal trochlear nerve morphology', 0.4246575342465753, 9.57905464648184, 2.0168831712789363, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523331, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0100739', 'abnormal hypoglossal nerve', 0.4696969696969697, 9.57905464648184, 2.1211442525236697, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523332, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0101879', 'abnormal cranial ganglion morphology', 0.4153846153846154, 7.318748312764234, 1.7435869502248444, 'HP:0000759', 'Abnormal peripheral nervous system morphology'),
(523333, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0103173', 'abnormal olfactory nerve morphology', 0.40789473684210525, 9.57905464648184, 1.9766754853093251, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523334, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0131688', 'abnormal mandibular nerve', 0.4482758620689655, 8.429051634704384, 1.9438468015692314, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523335, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0131670', 'abnormal maxillary nerve', 0.4482758620689655, 8.429051634704384, 1.9438468015692314, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523336, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0101746', 'abnormal peripheral nervous system morphology', 0.40384615384615385, 7.318748312764234, 1.7191999177169197, 'HP:0000759', 'Abnormal peripheral nervous system morphology'),
(523337, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0101458', 'abnormal vestibulocochlear ganglion', 0.47619047619047616, 9.57905464648184, 2.135756211172703, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523338, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0125655', 'absent accessory nerve', 0.40789473684210525, 9.57905464648184, 1.9766754853093251, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523339, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0127299', 'abnormally localised accessory nerve', 0.4305555555555556, 9.57905464648184, 2.0308410068277167, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523340, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0131679', 'abnormal frontal nerve', 0.4482758620689655, 8.429051634704384, 1.9438468015692314, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523341, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0102481', 'abnormal abducens nerve morphology', 0.41333333333333333, 9.57905464648184, 1.9898096861791816, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523342, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0101541', 'abnormal olfactory nerve', 0.4406779661016949, 8.429051634704384, 1.9273031236802618, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523343, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0100111', 'abnormal cranial nerve', 0.4642857142857143, 8.429051634704384, 1.978253840883392, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523344, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0103228', 'abnormal accessory nerve morphology', 0.41333333333333333, 9.57905464648184, 1.9898096861791816, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523345, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0141281', 'abnormal cephalic nerve morphology', 0.4264705882352941, 8.429051634704384, 1.8959806457129371, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523346, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0101185', 'abnormal vestibulocochlear nerve', 0.4918032786885246, 9.57905464648184, 2.1704862316716764, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523347, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0101427', 'abnormal ampullary nerve', 0.4838709677419355, 9.57905464648184, 2.152911155121375, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523348, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0127043', 'abnormally localised abducens nerve', 0.4305555555555556, 9.57905464648184, 2.0308410068277167, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523349, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0131536', 'abnormally localised cephalic nerve', 0.4090909090909091, 8.429051634704384, 1.8569459862945477, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523350, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0101421', 'abnormal oculomotor nerve', 0.45614035087719296, 8.429051634704384, 1.9608239518671824, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523351, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0101118', 'abnormal trochlear nerve', 0.45614035087719296, 8.429051634704384, 1.9608239518671824, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523352, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0100223', 'abnormal facial nerve', 0.6333333333333333, 12.627087342903641, 2.8279242064051693, 'HP:0010827', 'Abnormal seventh cranial physiology'),
(523353, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0101596', 'abnormal accessory nerve', 0.5084745762711864, 9.57905464648184, 2.2069675467592162, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523354, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0141312', 'abnormal maxillary nerve morphology', 0.4246575342465753, 9.57905464648184, 2.0168831712789363, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523355, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0141300', 'abnormal mandibular nerve morphology', 0.4246575342465753, 9.57905464648184, 2.0168831712789363, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523356, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0100635', 'abnormal sympathetic chain', 0.4074074074074074, 8.429051634704384, 1.853121170727398, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523357, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0128759', 'decreased size of the facial nerve', 0.4318181818181818, 12.627087342903641, 2.3350815613318576, 'HP:0010827', 'Abnormal seventh cranial physiology'),
(523358, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0141297', 'abnormal frontal nerve morphology', 0.4246575342465753, 9.57905464648184, 2.0168831712789363, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523359, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0125408', 'absent abducens nerve', 0.4025974025974026, 9.57905464648184, 1.963797983503438, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523360, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0103564', 'decreased length of facial nerve', 0.41304347826086957, 12.627087342903641, 2.2837548196811146, 'HP:0010827', 'Abnormal seventh cranial physiology'),
(523361, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0101030', 'abnormal spinal nerve', 0.4230769230769231, 8.429051634704384, 1.8884218887916013, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523362, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0126252', 'absent facial nerve', 0.48717948717948717, 12.627087342903641, 2.48025360322012, 'HP:0010827', 'Abnormal seventh cranial physiology'),
(523363, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0127841', 'abnormally localised ampullary nerve', 0.4246575342465753, 9.57905464648184, 2.0168831712789363, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523364, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0101743', 'abnormal cranial nerve morphology', 0.44285714285714284, 9.57905464648184, 2.0596487011171067, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523365, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0100110', 'abnormal trigeminal nerve', 0.45614035087719296, 8.429051634704384, 1.9608239518671824, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523366, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0103053', 'abnormal oculomotor nerve morphology', 0.4246575342465753, 9.57905464648184, 2.0168831712789363, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523367, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0101207', 'abnormal glossopharyngeal nerve', 0.4406779661016949, 8.429051634704384, 1.9273031236802618, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523368, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0141303', 'abnormal nasociliary nerve morphology', 0.4246575342465753, 9.57905464648184, 2.0168831712789363, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523369, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0102967', 'abnormal vagus nerve morphology', 0.40789473684210525, 9.57905464648184, 1.9766754853093251, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523370, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0130237', 'increased size of the facial nerve', 0.4222222222222222, 12.627087342903641, 2.3089904456525736, 'HP:0010827', 'Abnormal seventh cranial physiology'),
(523371, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0101204', 'abnormal peripheral nerve', 0.44, 8.429051634704384, 1.925820012168824, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523372, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0141021', 'abnormally necrotic facial nerve', 0.4418604651162791, 12.627087342903641, 2.362077620739692, 'HP:0010827', 'Abnormal seventh cranial physiology'),
(523373, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0100849', 'abnormal abducens nerve', 0.5084745762711864, 9.57905464648184, 2.2069675467592162, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523374, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0126866', 'abnormally localised vestibulocochlear nerve', 0.4189189189189189, 9.57905464648184, 2.0032092294040127, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523375, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0131652', 'abnormal cephalic nerve', 0.4727272727272727, 8.429051634704384, 1.9961569554900145, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523376, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0101335', 'abnormal vagus nerve', 0.4406779661016949, 8.429051634704384, 1.9273031236802618, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523377, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0102817', 'abnormal vestibulocochlear nerve morphology', 0.4025974025974026, 9.57905464648184, 1.963797983503438, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523378, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0100167', 'abnormal nerve', 0.44, 8.429051634704384, 1.925820012168824, 'HP:0045010', 'Abnormal peripheral nerve morphology by anatomical site'),
(523379, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0101855', 'abnormal facial nerve morphology', 0.4935064935064935, 12.627087342903641, 2.496307192193421, 'HP:0010827', 'Abnormal seventh cranial physiology'),
(523380, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0127303', 'abnormally localised vestibulocochlear ganglion', 0.4189189189189189, 9.57905464648184, 2.0032092294040127, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523381, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0127916', 'abnormally localised facial nerve', 0.5135135135135135, 12.627087342903641, 2.5464053068780044, 'HP:0010827', 'Abnormal seventh cranial physiology'),
(523382, 'HP:0010827', 'Abnormal seventh cranial physiology', 'XPO:0101742', 'abnormal trigeminal nerve morphology', 0.41333333333333333, 9.57905464648184, 1.9898096861791816, 'UPHENO:0076772', 'abnormal cranial nerve morphology'),
(523383, 'HP:0009128', 'Aplasia/Hypoplasia involving the musculature of the extremities', 'XPO:0100768', 'abnormal pectoral girdle', 0.44680851063829785, 9.463856994035337, 2.0563394292768806, 'UPHENO:0002647', 'abnormal musculature of limb'),
(523384, 'HP:0009128', 'Aplasia/Hypoplasia involving the musculature of the extremities', 'XPO:0100852', 'abnormal interdigital region', 0.40625, 5.504475013697824, 1.4953905758412218, 'HP:0040064', 'Abnormality of limbs'),
(523385, 'HP:0009128', 'Aplasia/Hypoplasia involving the musculature of the extremities', 'XPO:0101732', 'abnormal muscle morphology', 0.4186046511627907, 6.895202660022325, 1.6989302234628096, 'HP:0011805', 'Abnormal skeletal muscle morphology'),
(523386, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0102216', 'abnormal vertebral column morphology', 0.42592592592592593, 6.272837960958401, 1.6345532468244968, 'UPHENO:0022529', 'abnormal postcranial axial skeleton morphology'),
(523387, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0102217', 'abnormal elastica externa morphology', 0.45454545454545453, 4.638757693672553, 1.452076521536181, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(523388, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0107372', 'abnormal flexural organ morphology', 0.43478260869565216, 4.638757693672553, 1.4201588541997616, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(523389, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0102093', 'abnormal craniofacial skeleton morphology', 0.40384615384615385, 6.211345574613551, 1.5838017617482976, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(523390, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0139774', 'abnormally necrotic elastica externa', 0.40816326530612246, 4.638757693672553, 1.3759979968056957, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(523391, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0102097', 'abnormal skeletal system morphology', 0.45454545454545453, 4.638757693672553, 1.452076521536181, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(523392, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0102806', 'abnormal articular system morphology', 0.4444444444444444, 4.638757693672553, 1.4358516936218344, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(523393, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0102144', 'abnormal cranial skeleton morphology', 0.42, 6.211345574613551, 1.61516721776344, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(523394, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0102054', 'abnormal notochord morphology', 0.43478260869565216, 4.638757693672553, 1.4201588541997616, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(523395, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0140019', 'abnormally necrotic skeletal system', 0.40816326530612246, 4.638757693672553, 1.3759979968056957, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(523396, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0100584', 'abnormal vertebral column', 0.4791666666666667, 6.272837960958401, 1.7337055275601352, 'UPHENO:0022529', 'abnormal postcranial axial skeleton morphology'),
(523397, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0102461', 'abnormal postcranial axial skeleton morphology', 0.46, 6.272837960958401, 1.69867756270602, 'UPHENO:0022529', 'abnormal postcranial axial skeleton morphology'),
(523398, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0102605', 'abnormal dermal skeleton morphology', 0.40816326530612246, 4.638757693672553, 1.3759979968056957, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(523399, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0102010', 'abnormal perichondrium morphology', 0.425531914893617, 4.638757693672553, 1.404969552736279, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(523400, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0102130', 'abnormal endoskeleton morphology', 0.40816326530612246, 4.638757693672553, 1.3759979968056957, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(523401, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0141723', 'abnormal posterior notochord morphology', 0.43478260869565216, 4.638757693672553, 1.4201588541997616, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(523402, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0102567', 'abnormal skeleton morphology', 0.43478260869565216, 4.638757693672553, 1.4201588541997616, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(523403, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0101957', 'abnormal axial skeleton morphology', 0.42857142857142855, 6.211345574613551, 1.6315652749010534, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(523404, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0100226', 'abnormal vertebral element', 0.42592592592592593, 6.272837960958401, 1.6345532468244968, 'UPHENO:0022529', 'abnormal postcranial axial skeleton morphology'),
(523405, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0141719', 'abnormal anterior notochord morphology', 0.43478260869565216, 4.638757693672553, 1.4201588541997616, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(523406, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0101860', 'abnormal skeletal subdivision morphology', 0.425531914893617, 4.638757693672553, 1.404969552736279, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(523407, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0126886', 'abnormally localised vertebral column', 0.40350877192982454, 6.272837960958401, 1.5909573036826314, 'UPHENO:0022529', 'abnormal postcranial axial skeleton morphology'),
(523408, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0100693', 'abnormal vertebral centrum', 0.41818181818181815, 6.272837960958401, 1.6196255072310737, 'UPHENO:0022529', 'abnormal postcranial axial skeleton morphology'),
(523409, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0140510', 'abnormally necrotic postcranial axial skeleton', 0.4107142857142857, 6.272837960958401, 1.6050994245019483, 'UPHENO:0022529', 'abnormal postcranial axial skeleton morphology'),
(523410, 'HP:0100013', 'Neoplasm of the breast', 'XPO:0102272', 'abnormal notochordal sheath morphology', 0.43478260869565216, 4.638757693672553, 1.4201588541997616, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(523411, 'HP:0008883', 'Mild intrauterine growth retardation', 'XPO:0141598', 'decreased metamorphosis', 0.4722222222222222, 10.04714291694911, 2.17818368261861, 'UPHENO:0005597', 'decreased developmental process'),
(523412, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0141330', 'edematous epidermis', 0.42105263157894735, 11.189682030596343, 2.1705863414096775, 'HP:0011124', 'Abnormal epidermal morphology'),
(523413, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0101640', 'abnormal epidermis morphology', 0.43636363636363634, 11.189682030596343, 2.209699151609526, 'UPHENO:0020750', 'abnormal skin epidermis morphology'),
(523414, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0101804', 'abnormal stem cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523415, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0130896', 'increased size of the skin seromucous gland', 0.40384615384615385, 7.420886955069779, 1.7311547172139254, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523416, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0128803', 'decreased size of the dermis', 0.42857142857142855, 7.420886955069779, 1.7833620281931915, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523417, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0129993', 'increased size of the Eberth-Kastschenko layer', 0.4117647058823529, 7.420886955069779, 1.7480444314835069, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523418, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102852', 'abnormal centriole morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523419, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102113', 'abnormal anatomical line morphology', 0.4642857142857143, 2.786899518863159, 1.1375050038386183, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523420, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102285', 'abnormal myoblast morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523421, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0101890', 'abnormal organ part morphology', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523422, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102205', 'abnormal extraembryonic structure morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523423, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102109', 'abnormal pericyte morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523424, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102177', 'abnormal male organism morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523425, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0100983', 'abnormal skin gland', 0.4166666666666667, 6.8660902472206855, 1.6914109306558096, 'HP:0000951', 'Abnormality of the skin'),
(523426, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102360', 'abnormal cell condensation morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523427, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0140156', 'abnormally necrotic neuromast mantle cell', 0.4375, 7.420886955069779, 1.8018429573198183, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523428, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0141277', 'abnormal actin cytoskeleton morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523429, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0141219', 'abnormally necrotic granular gland', 0.42, 7.420886955069779, 1.7654383368244009, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523430, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0103161', 'abnormal skin mucous gland morphology', 0.44680851063829785, 7.420886955069779, 1.8209106095604752, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523431, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0103067', 'abnormal paracrine cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523432, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0129582', 'increased size of the portion of organism substance', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523433, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0101694', 'abnormal anatomical space morphology', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523434, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102423', 'abnormal multiciliated cell precursor morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523435, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0107347', 'abnormal anterior-posterior axis morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523436, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102910', 'abnormal pigment cell morphology', 0.4772727272727273, 7.420886955069779, 1.881963590463099, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523437, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0139841', 'abnormally necrotic anatomical region', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523438, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0107359', 'abnormal axial region morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523439, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0141342', 'decreased pigmentation in the epidermis', 0.41379310344827586, 11.189682030596343, 2.151793032342996, 'HP:0011124', 'Abnormal epidermal morphology'),
(523440, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0129487', 'increased size of the anatomical structure', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523441, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0101713', 'abnormal anatomical entity in vitro morphology', 0.4642857142857143, 2.786899518863159, 1.1375050038386183, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523442, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0103179', 'abnormal lampbrush chromosome morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523443, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0100507', 'abnormal skin', 0.42857142857142855, 6.8660902472206855, 1.7154037734456928, 'HP:0000951', 'Abnormality of the skin'),
(523444, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0140591', 'abnormally necrotic skin gland', 0.44680851063829785, 7.420886955069779, 1.8209106095604752, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523445, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0103223', 'abnormal xanthophore morphology', 0.45652173913043476, 7.420886955069779, 1.8405967017841829, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523446, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0139718', 'abnormally necrotic anatomical structure', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523447, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0129230', 'decreased size of the stratum spongiosum', 0.4117647058823529, 7.420886955069779, 1.7480444314835069, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523448, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0100994', 'abnormal granular gland', 0.40540540540540543, 6.8660902472206855, 1.6683974647021622, 'HP:0000951', 'Abnormality of the skin'),
(523449, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102353', 'abnormal centromere morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523450, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0107349', 'abnormal left-right axis morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523451, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0140144', 'abnormally necrotic portion of organism substance', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523452, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0130126', 'increased size of the stratum compactum', 0.4117647058823529, 7.420886955069779, 1.7480444314835069, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523453, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0130281', 'increased size of the dermis', 0.42857142857142855, 7.420886955069779, 1.7833620281931915, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523454, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0107345', 'abnormal anatomical axis morphology', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523455, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0103080', 'abnormal myelin accumulating cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523456, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0140581', 'abnormally necrotic stratum compactum', 0.42857142857142855, 7.420886955069779, 1.7833620281931915, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523457, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0141285', 'abnormal cortical actin cytoskeleton morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523458, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0107357', 'abnormal proximal-distal axis morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523459, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0128647', 'decreased size of the stratum compactum', 0.4117647058823529, 7.420886955069779, 1.7480444314835069, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523460, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0107348', 'abnormal dorsal-ventral axis morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523461, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102024', 'abnormal cilium morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523462, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0103104', 'abnormal zygote cortex morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523463, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102958', 'abnormal cementoblast morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523464, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0129655', 'increased size of the skin', 0.42857142857142855, 7.420886955069779, 1.7833620281931915, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523465, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102929', 'abnormal barrier cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523466, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0140061', 'abnormally necrotic pigment cell', 0.4375, 7.420886955069779, 1.8018429573198183, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523467, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102165', 'abnormal melanoblast morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523468, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0107346', 'abnormal animal-vegetal axis morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523469, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102347', 'abnormal ciliated cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523470, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102886', 'abnormal stratum compactum morphology', 0.4772727272727273, 7.420886955069779, 1.881963590463099, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523471, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102133', 'abnormal urogenital system morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523472, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102520', 'abnormal microtubule morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523473, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0103019', 'abnormal melanophore morphology', 0.45652173913043476, 7.420886955069779, 1.8405967017841829, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523474, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0107350', 'abnormal anatomical side morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523475, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102945', 'abnormal Eberth-Kastschenko layer morphology', 0.4772727272727273, 7.420886955069779, 1.881963590463099, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523476, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102381', 'abnormal mucociliary epithelium morphology', 0.41509433962264153, 8.516821552129047, 1.8802352028043958, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(523477, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102176', 'abnormal neuromast support cell morphology', 0.4772727272727273, 7.420886955069779, 1.881963590463099, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523478, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102789', 'abnormal female organism morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523479, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102055', 'abnormal process morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523480, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102336', 'abnormal Merkel cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523481, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0101716', 'abnormal anatomical group morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523482, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0103043', 'abnormal marginal zone (sensu neural) morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523483, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102323', 'abnormal keratin accumulating cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523484, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0140540', 'abnormally necrotic dermis', 0.44680851063829785, 7.420886955069779, 1.8209106095604752, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523485, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0103099', 'abnormal alkali secreting cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523486, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102693', 'abnormal plasma membrane morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523487, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0101871', 'abnormal acellular anatomical structure morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523488, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0103093', 'abnormal sperm entry point morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523489, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0128102', 'decreased size of the portion of organism substance', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523490, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102703', 'abnormal endoplasmic reticulum morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523491, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102954', 'abnormal iridophore morphology', 0.45652173913043476, 7.420886955069779, 1.8405967017841829, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523492, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0101969', 'abnormal zygote morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523493, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0141505', 'abnormal tadpole morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523494, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0129982', 'increased size of the anatomical line', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523495, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0128513', 'decreased size of the Eberth-Kastschenko layer', 0.4117647058823529, 7.420886955069779, 1.7480444314835069, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523496, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0140154', 'abnormally necrotic skin', 0.44680851063829785, 7.420886955069779, 1.8209106095604752, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523497, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0115316', 'abnormally neoplastic epidermis', 0.41379310344827586, 11.189682030596343, 2.151793032342996, 'UPHENO:0020750', 'abnormal skin epidermis morphology'),
(523498, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102588', 'abnormal centrosome morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523499, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0100929', 'abnormal dermis', 0.40540540540540543, 6.8660902472206855, 1.6683974647021622, 'HP:0000951', 'Abnormality of the skin'),
(523500, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0128502', 'decreased size of the anatomical line', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523501, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102979', 'abnormal hindlimb region morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523502, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0101638', 'abnormal anatomical structure morphology', 0.4642857142857143, 2.786899518863159, 1.1375050038386183, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523503, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0130438', 'increased size of the granular gland', 0.40384615384615385, 7.420886955069779, 1.7311547172139254, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523504, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0103147', 'abnormal neuromast mantle cell morphology', 0.4772727272727273, 7.420886955069779, 1.881963590463099, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523505, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0141205', 'abnormally necrotic skin seromucous gland', 0.42, 7.420886955069779, 1.7654383368244009, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523506, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0101917', 'abnormal progenitor cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523507, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102139', 'abnormal skin morphology', 0.5121951219512195, 7.420886955069779, 1.9496004972655756, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523508, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0128007', 'decreased size of the anatomical structure', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523509, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0140269', 'abnormally necrotic anatomical line', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523510, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0101740', 'abnormal cell part morphology', 0.4411764705882353, 2.786899518863159, 1.1088347458553505, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523511, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0141299', 'abnormal actin filament morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523512, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0140539', 'abnormally necrotic Eberth-Kastschenko layer', 0.42857142857142855, 7.420886955069779, 1.7833620281931915, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523513, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102636', 'abnormal acid secreting cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523514, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102356', 'abnormal kinetochore morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523515, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102773', 'abnormal Keller explant morphology', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523516, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102869', 'abnormal mucus secreting cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523517, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0101921', 'abnormal chondroblast morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523518, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0129422', 'decreased size of the skin seromucous gland', 0.40384615384615385, 7.420886955069779, 1.7311547172139254, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523519, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102741', 'abnormal egg cell-free extract morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523520, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102727', 'abnormal skin seromucous gland morphology', 0.4883720930232558, 7.420886955069779, 1.9037211177944116, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523521, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0141057', 'abnormally necrotic iridophore', 0.4117647058823529, 7.420886955069779, 1.7480444314835069, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523522, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0103145', 'abnormal basal body morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523523, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0103167', 'abnormal absorptive cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523524, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0101095', 'abnormal skin seromucous gland', 0.40540540540540543, 6.8660902472206855, 1.6683974647021622, 'HP:0000951', 'Abnormality of the skin'),
(523525, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0140701', 'abnormally necrotic neuromast support cell', 0.4375, 7.420886955069779, 1.8018429573198183, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523526, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102539', 'abnormal cytoplasm morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523527, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0101636', 'abnormal cell morphology', 0.42857142857142855, 2.786899518863159, 1.092879457252359, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523528, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0115510', 'abnormal degeneration of whole organism', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523529, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0101976', 'abnormal portion of organism substance morphology', 0.4642857142857143, 2.786899518863159, 1.1375050038386183, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523530, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102181', 'abnormal mitotic cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523531, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102965', 'abnormal barrier epithelial cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523532, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0140481', 'abnormally necrotic melanophore', 0.4117647058823529, 7.420886955069779, 1.7480444314835069, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523533, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0142064', 'abnormal desmosome morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523534, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102764', 'abnormal apoptotic cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523535, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0115317', 'abnormally incomplete structure of epidermis', 0.42857142857142855, 11.189682030596343, 2.189880821668777, 'UPHENO:0020750', 'abnormal skin epidermis morphology'),
(523536, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102626', 'abnormal granular gland morphology', 0.4883720930232558, 7.420886955069779, 1.9037211177944116, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523537, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102526', 'abnormal nucleus morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523538, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102561', 'abnormal dermis morphology', 0.5, 7.420886955069779, 1.9262511460178005, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523539, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0128960', 'decreased size of the granular gland', 0.40384615384615385, 7.420886955069779, 1.7311547172139254, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523540, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102896', 'abnormal mitotic spindle morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523541, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0107399', 'abnormal filopodium morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523542, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102601', 'abnormal disaggregated/reaggregated ectoderm treated with activin morphology', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523543, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0140235', 'abnormally necrotic stratum spongiosum', 0.42857142857142855, 7.420886955069779, 1.7833620281931915, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523544, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102646', 'abnormal goblet cell morphology', 0.4375, 7.420886955069779, 1.8018429573198183, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523545, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0101642', 'abnormal multicellular anatomical structure morphology', 0.41935483870967744, 2.786899518863159, 1.0810641970914296, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523546, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0128175', 'decreased size of the skin', 0.42857142857142855, 7.420886955069779, 1.7833620281931915, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523547, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0141296', 'abnormal adherens junction morphology', 0.4166666666666667, 2.786899518863159, 1.0775936770692605, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523548, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0103202', 'abnormal forelimb region morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523549, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0130706', 'increased size of the stratum spongiosum', 0.4117647058823529, 7.420886955069779, 1.7480444314835069, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523550, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102615', 'abnormal skin gland morphology', 0.5121951219512195, 7.420886955069779, 1.9496004972655756, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523551, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0101658', 'abnormal germ cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523552, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102840', 'abnormal stratum spongiosum morphology', 0.4772727272727273, 7.420886955069779, 1.881963590463099, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523553, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0103201', 'abnormal activin-induced ectoderm morphology', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523554, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0141336', 'increased pigmentation in the epidermis', 0.41379310344827586, 11.189682030596343, 2.151793032342996, 'UPHENO:0020750', 'abnormal skin epidermis morphology'),
(523555, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0140698', 'abnormally necrotic xanthophore', 0.4117647058823529, 7.420886955069779, 1.7480444314835069, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523556, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102178', 'abnormal whole organism morphology', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523557, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0128878', 'decreased size of the skin gland', 0.42857142857142855, 7.420886955069779, 1.7833620281931915, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523558, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102386', 'abnormal electrically active cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523559, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0141316', 'abnormal anatomical region morphology', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523560, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102275', 'abnormal thoracic region morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523561, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102434', 'abnormal exocrine cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523562, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0103005', 'abnormal oxygen accumulating cell morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523563, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102742', 'abnormal cell-free extract morphology', 0.43333333333333335, 2.786899518863159, 1.0989342374200721, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523564, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102064', 'abnormal epidermis inner layer morphology', 0.4074074074074074, 8.516821552129047, 1.8627442626148192, 'UPHENO:0087435', 'abnormal skin epidermis morphology'),
(523565, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102873', 'abnormal nucleate erythrocyte morphology', 0.40540540540540543, 2.786899518863159, 1.0629318554210558, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523566, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0102832', 'abnormal joint region morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523567, 'HP:0034840', 'Absence of epidermal lamellar bodies', 'XPO:0130356', 'increased size of the skin gland', 0.42857142857142855, 7.420886955069779, 1.7833620281931915, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(523568, 'HP:0031808', 'Decreased basophil count', 'XPO:0131221', 'abnormally decreased number of thymocyte', 0.41346153846153844, 9.649807419403725, 1.9974544353962702, 'UPHENO:0085330', 'abnormally decreased number of leukocyte'),
(523569, 'HP:0200056', 'Macular scar', 'XPO:0115417', 'abnormally wholly ventralized eye', 0.4069767441860465, 6.887869297006056, 1.6742767456052652, 'HP:0012372', 'Abnormal eye morphology'),
(523570, 'HP:0200056', 'Macular scar', 'XPO:0128295', 'decreased size of the retinal neural layer', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523571, 'HP:0200056', 'Macular scar', 'XPO:0129138', 'decreased size of the retinal progenitor cell', 0.41346153846153844, 8.040873045973026, 1.8233463028623837, 'HP:0000479', 'Abnormal retinal morphology'),
(523572, 'HP:0200056', 'Macular scar', 'XPO:0140553', 'abnormally necrotic retinal stem cell region', 0.5058823529411764, 8.040873045973026, 2.0168628550791743, 'HP:0000479', 'Abnormal retinal morphology'),
(523573, 'HP:0200056', 'Macular scar', 'XPO:0141337', 'increased pigmentation in the eye', 0.4268292682926829, 6.887869297006056, 1.714626551799759, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(523574, 'HP:0200056', 'Macular scar', 'XPO:0101961', 'abnormal retinal blood vessel morphology', 0.45263157894736844, 8.040873045973026, 1.9077612698957138, 'HP:0000479', 'Abnormal retinal morphology'),
(523575, 'HP:0200056', 'Macular scar', 'XPO:0102162', 'abnormal ciliary marginal zone morphology', 0.5, 8.040873045973026, 2.0051026215599324, 'HP:0000479', 'Abnormal retinal morphology'),
(523576, 'HP:0200056', 'Macular scar', 'XPO:0129285', 'decreased size of the retinal inner plexiform layer', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523577, 'HP:0200056', 'Macular scar', 'XPO:0130189', 'increased size of the optic chiasm', 0.41, 7.796308075334707, 1.7878720062933, 'UPHENO:0021656', 'abnormal ocular fundus morphology'),
(523578, 'HP:0200056', 'Macular scar', 'XPO:0102513', 'abnormal sclera morphology', 0.4375, 6.887869297006056, 1.7359270772241988, 'HP:0012372', 'Abnormal eye morphology'),
(523579, 'HP:0200056', 'Macular scar', 'XPO:0102851', 'abnormal retinal rod cell morphology', 0.44329896907216493, 8.040873045973026, 1.8879911895239345, 'HP:0000479', 'Abnormal retinal morphology'),
(523580, 'HP:0200056', 'Macular scar', 'XPO:0133372', 'eye fused with olfactory epithelium', 0.4268292682926829, 6.887869297006056, 1.714626551799759, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(523581, 'HP:0200056', 'Macular scar', 'XPO:0130265', 'increased size of the peripheral retina', 0.48314606741573035, 8.040873045973026, 1.9710190741722953, 'HP:0000479', 'Abnormal retinal morphology'),
(523582, 'HP:0200056', 'Macular scar', 'XPO:0128875', 'decreased size of the photoreceptor layer', 0.43434343434343436, 8.040873045973026, 1.8688232698432123, 'HP:0000479', 'Abnormal retinal morphology'),
(523583, 'HP:0200056', 'Macular scar', 'XPO:0102505', 'abnormal retinal stem cell region morphology', 0.524390243902439, 8.040873045973026, 2.053425279323877, 'HP:0000479', 'Abnormal retinal morphology'),
(523584, 'HP:0200056', 'Macular scar', 'XPO:0140346', 'abnormally necrotic retinal blood vessel', 0.4215686274509804, 8.040873045973026, 1.8411354685352277, 'HP:0000479', 'Abnormal retinal morphology'),
(523585, 'HP:0200056', 'Macular scar', 'XPO:0102117', 'abnormal retina morphology', 0.5512820512820513, 8.040873045973026, 2.1054189575670126, 'HP:0000479', 'Abnormal retinal morphology'),
(523586, 'HP:0200056', 'Macular scar', 'XPO:0140948', 'abnormally necrotic retinal inner nuclear layer', 0.43434343434343436, 8.040873045973026, 1.8688232698432123, 'HP:0000479', 'Abnormal retinal morphology'),
(523587, 'HP:0200056', 'Macular scar', 'XPO:0140240', 'abnormally necrotic eye photoreceptor cell', 0.43434343434343436, 8.040873045973026, 1.8688232698432123, 'HP:0000479', 'Abnormal retinal morphology'),
(523588, 'HP:0200056', 'Macular scar', 'XPO:0128431', 'decreased size of the retinal inner nuclear layer', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523589, 'HP:0200056', 'Macular scar', 'XPO:0128475', 'decreased size of the retinal stem cell region', 0.4942528735632184, 8.040873045973026, 1.9935457378573478, 'HP:0000479', 'Abnormal retinal morphology'),
(523590, 'HP:0200056', 'Macular scar', 'XPO:0129681', 'increased size of the eye photoreceptor cell', 0.40186915887850466, 8.040873045973026, 1.797603651429875, 'HP:0000479', 'Abnormal retinal morphology'),
(523591, 'HP:0200056', 'Macular scar', 'XPO:0140491', 'abnormally necrotic retinal rod cell', 0.4215686274509804, 8.040873045973026, 1.8411354685352277, 'HP:0000479', 'Abnormal retinal morphology'),
(523592, 'HP:0200056', 'Macular scar', 'XPO:0130906', 'increased size of the retinal stem cell', 0.41346153846153844, 8.040873045973026, 1.8233463028623837, 'HP:0000479', 'Abnormal retinal morphology'),
(523593, 'HP:0200056', 'Macular scar', 'XPO:0102831', 'abnormal optic disc morphology', 0.40789473684210525, 6.575878401988876, 1.6377625561371638, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(523594, 'HP:0200056', 'Macular scar', 'XPO:0139912', 'abnormally necrotic optic fiber layer', 0.43434343434343436, 8.040873045973026, 1.8688232698432123, 'HP:0000479', 'Abnormal retinal morphology'),
(523595, 'HP:0200056', 'Macular scar', 'XPO:0141014', 'abnormally necrotic retinal outer plexiform layer', 0.43434343434343436, 8.040873045973026, 1.8688232698432123, 'HP:0000479', 'Abnormal retinal morphology'),
(523596, 'HP:0200056', 'Macular scar', 'XPO:0103226', 'abnormal retinal outer plexiform layer morphology', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(523597, 'HP:0200056', 'Macular scar', 'XPO:0140006', 'abnormally necrotic retinal neural layer', 0.43434343434343436, 8.040873045973026, 1.8688232698432123, 'HP:0000479', 'Abnormal retinal morphology'),
(523598, 'HP:0200056', 'Macular scar', 'XPO:0102815', 'abnormal retinal ganglion cell morphology', 0.4387755102040816, 8.040873045973026, 1.8783338822565765, 'HP:0000479', 'Abnormal retinal morphology'),
(523599, 'HP:0200056', 'Macular scar', 'XPO:0130506', 'increased size of the Muller cell', 0.43434343434343436, 8.040873045973026, 1.8688232698432123, 'HP:0000479', 'Abnormal retinal morphology'),
(523600, 'HP:0200056', 'Macular scar', 'XPO:0140671', 'abnormally necrotic retinal ganglion cell', 0.4174757281553398, 8.040873045973026, 1.8321761186829812, 'HP:0000479', 'Abnormal retinal morphology'),
(523601, 'HP:0200056', 'Macular scar', 'XPO:0102963', 'abnormal retinal outer nuclear layer morphology', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(523602, 'HP:0200056', 'Macular scar', 'XPO:0129741', 'increased size of the optic fiber layer', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523603, 'HP:0200056', 'Macular scar', 'XPO:0140869', 'abnormally necrotic optic chiasm', 0.4270833333333333, 7.796308075334707, 1.8247392253435917, 'UPHENO:0021656', 'abnormal ocular fundus morphology'),
(523604, 'HP:0200056', 'Macular scar', 'XPO:0133371', 'eye fused with olfactory pit', 0.4268292682926829, 6.887869297006056, 1.714626551799759, 'HP:0012372', 'Abnormal eye morphology'),
(523605, 'HP:0200056', 'Macular scar', 'XPO:0133369', 'eye fused with brain', 0.4268292682926829, 6.887869297006056, 1.714626551799759, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(523606, 'HP:0200056', 'Macular scar', 'XPO:0102450', 'abnormal retinal stem cell morphology', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(523607, 'HP:0200056', 'Macular scar', 'XPO:0102784', 'abnormal retinal progenitor cell region morphology', 0.524390243902439, 8.040873045973026, 2.053425279323877, 'HP:0000479', 'Abnormal retinal morphology'),
(523608, 'HP:0200056', 'Macular scar', 'XPO:0102818', 'abnormal optic chiasm morphology', 0.45054945054945056, 7.796308075334707, 1.8741991141968606, 'UPHENO:0021656', 'abnormal ocular fundus morphology'),
(523609, 'HP:0200056', 'Macular scar', 'XPO:0141033', 'abnormally necrotic photoreceptor layer', 0.4387755102040816, 8.040873045973026, 1.8783338822565765, 'HP:0000479', 'Abnormal retinal morphology'),
(523610, 'HP:0200056', 'Macular scar', 'XPO:0140391', 'abnormally necrotic central retina', 0.5308641975308642, 8.040873045973026, 2.066061861851679, 'HP:0000479', 'Abnormal retinal morphology'),
(523611, 'HP:0200056', 'Macular scar', 'XPO:0101817', 'abnormal eye morphology', 0.4430379746835443, 6.887869297006056, 1.7468794071802813, 'HP:0012372', 'Abnormal eye morphology'),
(523612, 'HP:0200056', 'Macular scar', 'XPO:0139731', 'abnormally necrotic eye', 0.4069767441860465, 6.887869297006056, 1.6742767456052652, 'HP:0012372', 'Abnormal eye morphology'),
(523613, 'HP:0200056', 'Macular scar', 'XPO:0129580', 'increased size of the inner limiting membrane', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523614, 'HP:0200056', 'Macular scar', 'XPO:0128330', 'decreased size of the retinal progenitor cell region', 0.4942528735632184, 8.040873045973026, 1.9935457378573478, 'HP:0000479', 'Abnormal retinal morphology'),
(523615, 'HP:0200056', 'Macular scar', 'XPO:0129955', 'increased size of the retinal stem cell region', 0.4942528735632184, 8.040873045973026, 1.9935457378573478, 'HP:0000479', 'Abnormal retinal morphology'),
(523616, 'HP:0200056', 'Macular scar', 'XPO:0102196', 'abnormal central retina morphology', 0.5512820512820513, 8.040873045973026, 2.1054189575670126, 'HP:0000479', 'Abnormal retinal morphology'),
(523617, 'HP:0200056', 'Macular scar', 'XPO:0140192', 'abnormally necrotic retina', 0.5180722891566265, 8.040873045973026, 2.0410177622316423, 'HP:0000479', 'Abnormal retinal morphology'),
(523618, 'HP:0200056', 'Macular scar', 'XPO:0103184', 'abnormal inner limiting membrane morphology', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(523619, 'HP:0200056', 'Macular scar', 'XPO:0140464', 'abnormally necrotic retinal pigmented epithelium', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523620, 'HP:0200056', 'Macular scar', 'XPO:0140271', 'abnormally necrotic peripheral retina', 0.4942528735632184, 8.040873045973026, 1.9935457378573478, 'HP:0000479', 'Abnormal retinal morphology'),
(523621, 'HP:0200056', 'Macular scar', 'XPO:0103926', 'decreased pigmentation in the retinal pigmented epithelium', 0.45263157894736844, 8.040873045973026, 1.9077612698957138, 'HP:0000479', 'Abnormal retinal morphology'),
(523622, 'HP:0200056', 'Macular scar', 'XPO:0128300', 'decreased size of the retina', 0.5058823529411764, 8.040873045973026, 2.0168628550791743, 'HP:0000479', 'Abnormal retinal morphology'),
(523623, 'HP:0200056', 'Macular scar', 'XPO:0102239', 'abnormal retinal pigmented epithelium morphology', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(523624, 'HP:0200056', 'Macular scar', 'XPO:0103186', 'abnormal peripheral retina morphology', 0.5308641975308642, 8.040873045973026, 2.066061861851679, 'HP:0000479', 'Abnormal retinal morphology'),
(523625, 'HP:0200056', 'Macular scar', 'XPO:0100710', 'abnormal hyaloid vein', 0.4025974025974026, 6.887869297006056, 1.6652442128423794, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(523626, 'HP:0200056', 'Macular scar', 'XPO:0102232', 'abnormal eye photoreceptor cell morphology', 0.45263157894736844, 8.040873045973026, 1.9077612698957138, 'HP:0000479', 'Abnormal retinal morphology'),
(523627, 'HP:0200056', 'Macular scar', 'XPO:0140218', 'abnormally necrotic sclera', 0.4117647058823529, 6.887869297006056, 1.6840966347682629, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(523628, 'HP:0200056', 'Macular scar', 'XPO:0102805', 'abnormal retinal layer morphology', 0.5657894736842105, 8.040873045973026, 2.1329419421640696, 'HP:0000479', 'Abnormal retinal morphology'),
(523629, 'HP:0200056', 'Macular scar', 'XPO:0128787', 'decreased size of the peripheral retina', 0.48314606741573035, 8.040873045973026, 1.9710190741722953, 'HP:0000479', 'Abnormal retinal morphology'),
(523630, 'HP:0200056', 'Macular scar', 'XPO:0140945', 'abnormally necrotic retinal ganglion cell layer', 0.43434343434343436, 8.040873045973026, 1.8688232698432123, 'HP:0000479', 'Abnormal retinal morphology'),
(523631, 'HP:0200056', 'Macular scar', 'XPO:0102996', 'abnormal optic fiber layer morphology', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(523632, 'HP:0200056', 'Macular scar', 'XPO:0140520', 'abnormally necrotic retinal outer nuclear layer', 0.43434343434343436, 8.040873045973026, 1.8688232698432123, 'HP:0000479', 'Abnormal retinal morphology'),
(523633, 'HP:0200056', 'Macular scar', 'XPO:0128884', 'decreased size of the retinal pigmented epithelium', 0.42574257425742573, 8.040873045973026, 1.850227550835222, 'HP:0000479', 'Abnormal retinal morphology'),
(523634, 'HP:0200056', 'Macular scar', 'XPO:0129911', 'increased size of the retinal inner nuclear layer', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523635, 'HP:0200056', 'Macular scar', 'XPO:0141333', 'increased pigmentation in the retinal pigmented epithelium', 0.45263157894736844, 8.040873045973026, 1.9077612698957138, 'HP:0000479', 'Abnormal retinal morphology'),
(523636, 'HP:0200056', 'Macular scar', 'XPO:0140317', 'abnormally necrotic retinal progenitor cell', 0.4479166666666667, 8.040873045973026, 1.8977990019604511, 'HP:0000479', 'Abnormal retinal morphology'),
(523637, 'HP:0200056', 'Macular scar', 'XPO:0128261', 'decreased size of the optic fiber layer', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523638, 'HP:0200056', 'Macular scar', 'XPO:0128643', 'decreased size of the retinal layer', 0.5180722891566265, 8.040873045973026, 2.0410177622316423, 'HP:0000479', 'Abnormal retinal morphology'),
(523639, 'HP:0200056', 'Macular scar', 'XPO:0101359', 'abnormal hyaloid artery', 0.40229885057471265, 6.887869297006056, 1.6646266551675757, 'HP:0012372', 'Abnormal eye morphology'),
(523640, 'HP:0200056', 'Macular scar', 'XPO:0130257', 'increased size of the retinal blood vessel', 0.41346153846153844, 8.040873045973026, 1.8233463028623837, 'HP:0000479', 'Abnormal retinal morphology'),
(523641, 'HP:0200056', 'Macular scar', 'XPO:0101861', 'abnormal photoreceptor layer morphology', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(523642, 'HP:0200056', 'Macular scar', 'XPO:0141343', 'decreased pigmentation in the eye', 0.4268292682926829, 6.887869297006056, 1.714626551799759, 'HP:0012372', 'Abnormal eye morphology'),
(523643, 'HP:0200056', 'Macular scar', 'XPO:0140081', 'abnormally necrotic amacrine cell', 0.4095238095238095, 8.040873045973026, 1.8146429295275122, 'HP:0000479', 'Abnormal retinal morphology'),
(523644, 'HP:0200056', 'Macular scar', 'XPO:0129810', 'increased size of the retinal progenitor cell region', 0.4942528735632184, 8.040873045973026, 1.9935457378573478, 'HP:0000479', 'Abnormal retinal morphology'),
(523645, 'HP:0200056', 'Macular scar', 'XPO:0100329', 'abnormal retinal blood vessel', 0.5584415584415584, 8.040873045973026, 2.1190464070010115, 'HP:0000479', 'Abnormal retinal morphology'),
(523646, 'HP:0200056', 'Macular scar', 'XPO:0102441', 'abnormal retinal inner plexiform layer morphology', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(523647, 'HP:0200056', 'Macular scar', 'XPO:0128710', 'decreased size of the optic chiasm', 0.41, 7.796308075334707, 1.7878720062933, 'UPHENO:0021656', 'abnormal ocular fundus morphology'),
(523648, 'HP:0200056', 'Macular scar', 'XPO:0130362', 'increased size of the retinal pigmented epithelium', 0.42574257425742573, 8.040873045973026, 1.850227550835222, 'HP:0000479', 'Abnormal retinal morphology'),
(523649, 'HP:0200056', 'Macular scar', 'XPO:0102939', 'abnormal retinal ganglion cell layer morphology', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(523650, 'HP:0200056', 'Macular scar', 'XPO:0102550', 'abnormal lens morphology', 0.42168674698795183, 6.887869297006056, 1.7042661756699493, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(523651, 'HP:0200056', 'Macular scar', 'XPO:0140439', 'abnormally necrotic retinal stem cell', 0.4479166666666667, 8.040873045973026, 1.8977990019604511, 'HP:0000479', 'Abnormal retinal morphology'),
(523652, 'HP:0200056', 'Macular scar', 'XPO:0100779', 'abnormal optic choroid vascular plexus', 0.40789473684210525, 6.887869297006056, 1.6761639640277146, 'HP:0012372', 'Abnormal eye morphology'),
(523653, 'HP:0200056', 'Macular scar', 'XPO:0129371', 'decreased size of the retinal outer plexiform layer', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523654, 'HP:0200056', 'Macular scar', 'XPO:0130353', 'increased size of the photoreceptor layer', 0.43434343434343436, 8.040873045973026, 1.8688232698432123, 'HP:0000479', 'Abnormal retinal morphology'),
(523655, 'HP:0200056', 'Macular scar', 'XPO:0102476', 'abnormal lens transitional zone morphology', 0.4117647058823529, 6.887869297006056, 1.6840966347682629, 'HP:0012372', 'Abnormal eye morphology'),
(523656, 'HP:0200056', 'Macular scar', 'XPO:0130125', 'increased size of the outer limiting membrane', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523657, 'HP:0200056', 'Macular scar', 'XPO:0128501', 'decreased size of the retinal ganglion cell layer', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523658, 'HP:0200056', 'Macular scar', 'XPO:0133354', 'fused eyes', 0.4268292682926829, 6.887869297006056, 1.714626551799759, 'HP:0012372', 'Abnormal eye morphology'),
(523659, 'HP:0200056', 'Macular scar', 'XPO:0130863', 'increased size of the sclera', 0.40229885057471265, 6.887869297006056, 1.6646266551675757, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(523660, 'HP:0200056', 'Macular scar', 'XPO:0128646', 'decreased size of the outer limiting membrane', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523661, 'HP:0200056', 'Macular scar', 'XPO:0130614', 'increased size of the retinal progenitor cell', 0.41346153846153844, 8.040873045973026, 1.8233463028623837, 'HP:0000479', 'Abnormal retinal morphology'),
(523662, 'HP:0200056', 'Macular scar', 'XPO:0141156', 'abnormally necrotic outer limiting membrane', 0.43434343434343436, 8.040873045973026, 1.8688232698432123, 'HP:0000479', 'Abnormal retinal morphology'),
(523663, 'HP:0200056', 'Macular scar', 'XPO:0103155', 'abnormal bipolar neuron morphology', 0.43434343434343436, 8.040873045973026, 1.8688232698432123, 'HP:0000479', 'Abnormal retinal morphology'),
(523664, 'HP:0200056', 'Macular scar', 'XPO:0100371', 'abnormal hyaloid blood vessel', 0.41333333333333333, 6.887869297006056, 1.6873013886368484, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(523665, 'HP:0200056', 'Macular scar', 'XPO:0140620', 'abnormally necrotic horizontal cell', 0.42574257425742573, 8.040873045973026, 1.850227550835222, 'HP:0000479', 'Abnormal retinal morphology'),
(523666, 'HP:0200056', 'Macular scar', 'XPO:0141638', 'neoplastic eye', 0.4268292682926829, 6.887869297006056, 1.714626551799759, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(523667, 'HP:0200056', 'Macular scar', 'XPO:0140487', 'abnormally necrotic retinal layer', 0.524390243902439, 8.040873045973026, 2.053425279323877, 'HP:0000479', 'Abnormal retinal morphology'),
(523668, 'HP:0200056', 'Macular scar', 'XPO:0130515', 'increased size of the retinal outer nuclear layer', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523669, 'HP:0200056', 'Macular scar', 'XPO:0115423', 'abnormally incomplete structure of eye', 0.4375, 6.887869297006056, 1.7359270772241988, 'HP:0012372', 'Abnormal eye morphology'),
(523670, 'HP:0200056', 'Macular scar', 'XPO:0130413', 'increased size of the central retina', 0.5180722891566265, 8.040873045973026, 2.0410177622316423, 'HP:0000479', 'Abnormal retinal morphology'),
(523671, 'HP:0200056', 'Macular scar', 'XPO:0101315', 'abnormal hyaloid vascular plexus', 0.4025974025974026, 6.887869297006056, 1.6652442128423794, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(523672, 'HP:0200056', 'Macular scar', 'XPO:0102017', 'abnormal retinal neural layer morphology', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(523673, 'HP:0200056', 'Macular scar', 'XPO:0141138', 'abnormally necrotic retinal inner plexiform layer', 0.43434343434343436, 8.040873045973026, 1.8688232698432123, 'HP:0000479', 'Abnormal retinal morphology'),
(523674, 'HP:0200056', 'Macular scar', 'XPO:0140531', 'abnormally necrotic retinal progenitor cell region', 0.5058823529411764, 8.040873045973026, 2.0168628550791743, 'HP:0000479', 'Abnormal retinal morphology'),
(523675, 'HP:0200056', 'Macular scar', 'XPO:0102581', 'abnormal outer limiting membrane morphology', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(523676, 'HP:0200056', 'Macular scar', 'XPO:0141323', 'edematous eye', 0.43209876543209874, 6.887869297006056, 1.7251781994025936, 'HP:0012372', 'Abnormal eye morphology'),
(523677, 'HP:0200056', 'Macular scar', 'XPO:0103022', 'abnormal ciliary body morphology', 0.40229885057471265, 6.887869297006056, 1.6646266551675757, 'HP:0012372', 'Abnormal eye morphology'),
(523678, 'HP:0200056', 'Macular scar', 'XPO:0129388', 'decreased size of the sclera', 0.40229885057471265, 6.887869297006056, 1.6646266551675757, 'HP:0012372', 'Abnormal eye morphology'),
(523679, 'HP:0200056', 'Macular scar', 'XPO:0139887', 'abnormally necrotic Muller cell', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(523680, 'HP:0200056', 'Macular scar', 'XPO:0103048', 'abnormal cornea morphology', 0.40229885057471265, 6.887869297006056, 1.6646266551675757, 'HP:0012372', 'Abnormal eye morphology'),
(523681, 'HP:0200056', 'Macular scar', 'XPO:0128201', 'decreased size of the eye photoreceptor cell', 0.40186915887850466, 8.040873045973026, 1.797603651429875, 'HP:0000479', 'Abnormal retinal morphology'),
(523682, 'HP:0200056', 'Macular scar', 'XPO:0129432', 'decreased size of the retinal stem cell', 0.41346153846153844, 8.040873045973026, 1.8233463028623837, 'HP:0000479', 'Abnormal retinal morphology'),
(523683, 'HP:0200056', 'Macular scar', 'XPO:0141182', 'abnormally necrotic inner limiting membrane', 0.43434343434343436, 8.040873045973026, 1.8688232698432123, 'HP:0000479', 'Abnormal retinal morphology'),
(523684, 'HP:0200056', 'Macular scar', 'XPO:0128935', 'decreased size of the central retina', 0.5180722891566265, 8.040873045973026, 2.0410177622316423, 'HP:0000479', 'Abnormal retinal morphology'),
(523685, 'HP:0200056', 'Macular scar', 'XPO:0102663', 'abnormal retinal progenitor cell morphology', 0.4725274725274725, 8.040873045973026, 1.9492391893577128, 'HP:0000479', 'Abnormal retinal morphology'),
(523686, 'HP:0200056', 'Macular scar', 'XPO:0102756', 'abnormal Muller cell morphology', 0.5, 8.040873045973026, 2.0051026215599324, 'HP:0000479', 'Abnormal retinal morphology'),
(523687, 'HP:0200056', 'Macular scar', 'XPO:0129038', 'decreased size of the retinal outer nuclear layer', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523688, 'HP:0200056', 'Macular scar', 'XPO:0127563', 'abnormally localised retinal blood vessel', 0.4942528735632184, 8.040873045973026, 1.9935457378573478, 'HP:0000479', 'Abnormal retinal morphology'),
(523689, 'HP:0200056', 'Macular scar', 'XPO:0129775', 'increased size of the retinal neural layer', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523690, 'HP:0200056', 'Macular scar', 'XPO:0129029', 'decreased size of the Muller cell', 0.43434343434343436, 8.040873045973026, 1.8688232698432123, 'HP:0000479', 'Abnormal retinal morphology'),
(523691, 'HP:0200056', 'Macular scar', 'XPO:0129981', 'increased size of the retinal ganglion cell layer', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523692, 'HP:0200056', 'Macular scar', 'XPO:0128779', 'decreased size of the retinal blood vessel', 0.41346153846153844, 8.040873045973026, 1.8233463028623837, 'HP:0000479', 'Abnormal retinal morphology'),
(523693, 'HP:0200056', 'Macular scar', 'XPO:0140797', 'abnormally necrotic bipolar neuron', 0.4095238095238095, 8.040873045973026, 1.8146429295275122, 'HP:0000479', 'Abnormal retinal morphology'),
(523694, 'HP:0200056', 'Macular scar', 'XPO:0128669', 'decreased size of the ciliary marginal zone', 0.4479166666666667, 8.040873045973026, 1.8977990019604511, 'HP:0000479', 'Abnormal retinal morphology'),
(523695, 'HP:0200056', 'Macular scar', 'XPO:0102266', 'abnormal horizontal cell morphology', 0.4479166666666667, 8.040873045973026, 1.8977990019604511, 'HP:0000479', 'Abnormal retinal morphology'),
(523696, 'HP:0200056', 'Macular scar', 'XPO:0102946', 'abnormal retinal inner nuclear layer morphology', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(523697, 'HP:0200056', 'Macular scar', 'XPO:0130845', 'increased size of the retinal outer plexiform layer', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523698, 'HP:0200056', 'Macular scar', 'XPO:0130761', 'increased size of the retinal inner plexiform layer', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523699, 'HP:0200056', 'Macular scar', 'XPO:0125909', 'absent retinal blood vessel', 0.4673913043478261, 8.040873045973026, 1.938616553383523, 'HP:0000479', 'Abnormal retinal morphology'),
(523700, 'HP:0200056', 'Macular scar', 'XPO:0128100', 'decreased size of the inner limiting membrane', 0.43, 8.040873045973026, 1.859455675666511, 'HP:0000479', 'Abnormal retinal morphology'),
(523701, 'HP:0200056', 'Macular scar', 'XPO:0103086', 'abnormal amacrine cell morphology', 0.43434343434343436, 8.040873045973026, 1.8688232698432123, 'HP:0000479', 'Abnormal retinal morphology'),
(523702, 'HP:0200056', 'Macular scar', 'XPO:0140489', 'abnormally necrotic ciliary marginal zone', 0.4574468085106383, 8.040873045973026, 1.9178820903589395, 'HP:0000479', 'Abnormal retinal morphology'),
(523703, 'HP:0200056', 'Macular scar', 'XPO:0130122', 'increased size of the retinal layer', 0.5180722891566265, 8.040873045973026, 2.0410177622316423, 'HP:0000479', 'Abnormal retinal morphology'),
(523704, 'HP:0200056', 'Macular scar', 'XPO:0140808', 'abnormally necrotic retinal cone cell', 0.4215686274509804, 8.040873045973026, 1.8411354685352277, 'HP:0000479', 'Abnormal retinal morphology'),
(523705, 'HP:0200056', 'Macular scar', 'XPO:0129780', 'increased size of the retina', 0.5058823529411764, 8.040873045973026, 2.0168628550791743, 'HP:0000479', 'Abnormal retinal morphology'),
(523706, 'HP:0200056', 'Macular scar', 'XPO:0130148', 'increased size of the ciliary marginal zone', 0.4479166666666667, 8.040873045973026, 1.8977990019604511, 'HP:0000479', 'Abnormal retinal morphology'),
(523707, 'HP:0200056', 'Macular scar', 'XPO:0102882', 'abnormal retinal cone cell morphology', 0.44329896907216493, 8.040873045973026, 1.8879911895239345, 'HP:0000479', 'Abnormal retinal morphology'),
(523708, 'HP:0010188', 'Curved distal toe phalanx', 'XPO:0102566', 'abnormal claw primordium morphology', 0.41346153846153844, 7.639349617137506, 1.7772386574535335, 'HP:0001780', 'Abnormal toe morphology'),
(523709, 'HP:0010188', 'Curved distal toe phalanx', 'XPO:0101809', 'abnormal hindlimb digit morphology', 0.4095238095238095, 7.639349617137506, 1.7687553696015759, 'HP:0001780', 'Abnormal toe morphology'),
(523710, 'HP:0010188', 'Curved distal toe phalanx', 'XPO:0102051', 'abnormal hindlimb digit 2 morphology', 0.40186915887850466, 7.639349617137506, 1.752146970153439, 'HP:0001780', 'Abnormal toe morphology'),
(523711, 'HP:0010188', 'Curved distal toe phalanx', 'XPO:0102876', 'abnormal hindlimb digit 4 morphology', 0.40186915887850466, 7.639349617137506, 1.752146970153439, 'UPHENO:0088132', 'abnormal pedal digit morphology'),
(523712, 'HP:0010188', 'Curved distal toe phalanx', 'XPO:0102180', 'abnormal hindlimb digit 3 morphology', 0.40186915887850466, 7.639349617137506, 1.752146970153439, 'UPHENO:0088132', 'abnormal pedal digit morphology'),
(523713, 'HP:0010188', 'Curved distal toe phalanx', 'XPO:0102948', 'abnormal hindlimb digit 5 morphology', 0.40186915887850466, 7.639349617137506, 1.752146970153439, 'UPHENO:0088132', 'abnormal pedal digit morphology'),
(523714, 'HP:0010188', 'Curved distal toe phalanx', 'XPO:0101872', 'abnormal hindlimb digit 1 morphology', 0.40186915887850466, 7.639349617137506, 1.752146970153439, 'UPHENO:0088132', 'abnormal pedal digit morphology'),
(523715, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0128535', 'decreased size of the respiratory system', 0.5217391304347826, 7.241224942262181, 1.9437156182576012, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523716, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0141648', 'neoplastic lung', 0.46551724137931033, 9.627087342903641, 2.116973108564721, 'UPHENO:0019970', 'abnormal lung morphology'),
(523717, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0127882', 'abnormally localised pulmonary vein', 0.421875, 9.627087342903641, 2.0152983582555395, 'HP:0002088', 'Abnormal lung morphology'),
(523718, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0100586', 'abnormal thyroid primordium', 0.46153846153846156, 7.241224942262181, 1.8281421770490451, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523719, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0126220', 'absent pulmonary vein', 0.4090909090909091, 9.627087342903641, 1.9845286374870066, 'HP:0002088', 'Abnormal lung morphology'),
(523720, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0101036', 'abnormal pharynx', 0.5, 7.241224942262181, 1.9027907060764961, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523721, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0125232', 'absent pharynx', 0.42105263157894735, 7.241224942262181, 1.746120504946495, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523722, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0102113', 'abnormal anatomical line morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523723, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0141593', 'edematous lung', 0.46551724137931033, 9.627087342903641, 2.116973108564721, 'UPHENO:0019970', 'abnormal lung morphology'),
(523724, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0101976', 'abnormal portion of organism substance morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523725, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0127602', 'abnormally localised pulmonary artery', 0.421875, 9.627087342903641, 2.0152983582555395, 'UPHENO:0019970', 'abnormal lung morphology'),
(523726, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0101329', 'abnormal pharyngeal epithelium', 0.4897959183673469, 7.241224942262181, 1.8832743880539138, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523727, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0126197', 'absent larynx', 0.43636363636363634, 7.241224942262181, 1.777584666769093, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523728, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0100210', 'abnormal pulmonary artery', 0.5, 9.627087342903641, 2.19397895875321, 'HP:0002088', 'Abnormal lung morphology'),
(523729, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0100117', 'abnormal aortic arch', 0.4067796610169492, 7.241224942262181, 1.7162700916117157, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523730, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0126955', 'abnormally localised oropharynx', 0.4067796610169492, 7.241224942262181, 1.7162700916117157, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523731, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0102932', 'abnormal lung morphology', 0.4909090909090909, 9.627087342903641, 2.1739422015332517, 'UPHENO:0019970', 'abnormal lung morphology'),
(523732, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0141178', 'abnormally necrotic larynx', 0.4067796610169492, 7.241224942262181, 1.7162700916117157, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523733, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0101548', 'abnormal pulmonary vein', 0.5, 9.627087342903641, 2.19397895875321, 'HP:0002088', 'Abnormal lung morphology'),
(523734, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0102668', 'abnormal pharynx morphology', 0.42857142857142855, 7.241224942262181, 1.7616418813460253, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523735, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0102436', 'abnormal larynx morphology', 0.46153846153846156, 7.241224942262181, 1.8281421770490451, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523736, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0103175', 'abnormal external gill morphology', 0.4090909090909091, 7.034007514759976, 1.6963338494428049, 'UPHENO:0087433', 'abnormal respiratory system morphology'),
(523737, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0126855', 'abnormally localised pharynx', 0.42857142857142855, 7.241224942262181, 1.7616418813460253, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523738, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0139850', 'abnormally necrotic respiratory system', 0.5454545454545454, 7.241224942262181, 1.987400075328502, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523739, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0140598', 'abnormally necrotic lung', 0.4090909090909091, 9.627087342903641, 1.9845286374870066, 'UPHENO:0019970', 'abnormal lung morphology'),
(523740, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0101638', 'abnormal anatomical structure morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523741, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0141644', 'neoplastic larynx', 0.43636363636363634, 7.241224942262181, 1.777584666769093, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523742, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0100875', 'abnormal oropharynx', 0.47058823529411764, 7.241224942262181, 1.8459781328463531, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523743, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0127859', 'abnormally localised larynx', 0.4444444444444444, 7.241224942262181, 1.793968281927239, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523744, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0100804', 'abnormal larynx', 0.5454545454545454, 7.241224942262181, 1.987400075328502, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523745, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0141614', 'metaplastic larynx', 0.5106382978723404, 7.241224942262181, 1.922926618211807, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523746, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0130015', 'increased size of the respiratory system', 0.5217391304347826, 7.241224942262181, 1.9437156182576012, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523747, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0101713', 'abnormal anatomical entity in vitro morphology', 0.40625, 2.786899518863159, 1.0640385000262718, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(523748, 'HP:0033245', 'Abnormal alveolar type II pneumocyte morphology', 'XPO:0101949', 'abnormal respiratory system morphology', 0.6153846153846154, 7.241224942262181, 2.1109567560723494, 'HP:0012252', 'Abnormal respiratory system morphology'),
(523749, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141776', 'abnormal metabolic process', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(523750, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0115505', 'dead whole organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523751, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101535', 'abnormal absorptive cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523752, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100176', 'abnormal stage VI oocyte', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523753, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100164', 'abnormal neural nucleus', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523754, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0126537', 'abnormally localised hematological system', 0.41935483870967744, 5.574066539846944, 1.5288923359002506, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(523755, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100392', 'abnormal cilium', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523756, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100888', 'abnormal microtubule', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523757, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101004', 'abnormal acid secreting cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523758, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101040', 'abnormal axial mesoderm', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523759, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100186', 'abnormal uveal tract', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523760, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100289', 'abnormal chondroblast', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523761, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101409', 'abnormal perivitelline space', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523762, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100239', 'abnormal acellular anatomical structure', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523763, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100274', 'abnormal sensory system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523764, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100515', 'abnormal somatic stem cell', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523765, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100989', 'abnormal right blastomere', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523766, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141783', 'abnormal collagen metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(523767, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141315', 'abnormal anatomical region', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523768, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100501', 'abnormal urogenital system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523769, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141904', 'abnormal glucosamine metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(523770, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100273', 'abnormal visual system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523771, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101228', 'abnormal mesenchymal stem cell', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523772, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141784', 'abnormal cellular hormone metabolic process', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523773, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100742', 'abnormal musculoskeletal system', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523774, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100549', 'abnormal mitotic cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523775, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100842', 'abnormal left-dorsal blastomere', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523776, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101497', 'abnormal ciliary axoneme', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523777, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101450', 'abnormal myeloid cell', 0.5, 5.574066539846944, 1.6694410052240456, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(523778, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0102455', 'abnormal blood morphology', 0.41935483870967744, 5.574066539846944, 1.5288923359002506, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(523779, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141782', 'abnormal methylation', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(523780, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100894', 'abnormal nucleus', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523781, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100493', 'abnormal liver and biliary system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523782, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0131685', 'abnormal cortical actin cytoskeleton', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523783, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100363', 'abnormal cardiovascular system', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523784, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100417', 'abnormal dense regular connective tissue', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523785, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101463', 'abnormal right-ventral blastomere', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523786, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141745', 'abnormal creatinine homeostasis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523787, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101547', 'abnormal lampbrush chromosome', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523788, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141781', 'abnormal secondary metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(523789, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141266', 'abnormal surface breathing', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523790, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100574', 'abnormal gastrula cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523791, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100640', 'abnormal notochordal sheath', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523792, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100956', 'abnormal centrosome', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523793, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100031', 'abnormal central nervous system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523794, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101071', 'abnormal endoplasmic reticulum', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523795, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100135', 'abnormal surface structure', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523796, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100028', 'abnormal anatomical cluster', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523797, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100581', 'abnormal immune system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523798, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100002', 'abnormal head', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523799, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100999', 'abnormal serous membrane', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523800, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101389', 'abnormal wedge region', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523801, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141499', 'abnormal tadpole', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523802, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100386', 'abnormal limb', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523803, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100277', 'abnormal blastocoel', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523804, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100084', 'abnormal anatomical group', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523805, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100912', 'abnormal trabecula', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523806, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101373', 'abnormal oxygen accumulating cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523807, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141775', 'abnormal nitrogen compound metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(523808, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100533', 'abnormal melanoblast', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523809, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100599', 'abnormal adult immune system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523810, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107262', 'abnormal left-right axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523811, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100120', 'abnormal genital system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523812, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101109', 'abnormal egg cell-free extract', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523813, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101480', 'abnormal stage V oocyte', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523814, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100377', 'abnormal connective tissue', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523815, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100032', 'abnormal nervous system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523816, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100437', 'abnormal proepicardium', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523817, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0142057', 'abnormal desmosome', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523818, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101264', 'abnormal mitotic spindle', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523819, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101435', 'abnormal paracrine cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523820, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101333', 'abnormal barrier epithelial cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523821, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100653', 'abnormal myoblast', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523822, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100665', 'abnormal egg jelly', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523823, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100337', 'abnormal zygote', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523824, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100721', 'abnormal centromere', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523825, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100557', 'abnormal prime meridian', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523826, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0142052', 'abnormal nasal region', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523827, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100422', 'abnormal notochord', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523828, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0115508', 'abnormally peramorphic growth of whole organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523829, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141748', 'abnormal gas homeostasis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523830, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141797', 'abnormal hydrogen metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(523831, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100081', 'abnormal anatomical entity in vitro', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523832, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107273', 'abnormal basal region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523833, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100862', 'abnormal blastomere V1', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523834, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107268', 'abnormal left side', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523835, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100202', 'abnormal embryo', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523836, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101448', 'abnormal myelin accumulating cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523837, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100384', 'abnormal amputated tissue', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523838, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100688', 'abnormal adipose tissue', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523839, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107260', 'abnormal anterior-posterior axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523840, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100205', 'abnormal limb segment', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523841, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0126758', 'abnormally localised blood', 0.41935483870967744, 5.574066539846944, 1.5288923359002506, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(523842, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141772', 'abnormal water homeostasis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523843, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100511', 'abnormal stylopod', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523844, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100282', 'abnormal pelvic girdle primordium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523845, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101297', 'abnormal barrier cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523846, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0131687', 'abnormal astral microtubule', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523847, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141267', 'abnormal resting posture', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523848, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100009', 'abnormal multi-tissue structure', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523849, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100546', 'abnormal whole organism', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523850, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100026', 'abnormal germ cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523851, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101061', 'abnormal plasma membrane', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523852, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100674', 'abnormal secondary oogonium', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523853, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100781', 'abnormal presumptive ectoderm', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523854, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0124923', 'absent hematological system', 0.40625, 5.574066539846944, 1.5048137864243607, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(523855, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100339', 'abnormal circumblastoporal collar', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523856, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141771', 'abnormal urea homeostasis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523857, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100265', 'abnormal sensory epithelial cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523858, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100786', 'abnormal presumptive axial mesoderm', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523859, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100969', 'abnormal disaggregated/reaggregated ectoderm treated with activin', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523860, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107253', 'abnormal enteric nervous system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523861, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100913', 'abnormal Brachets cleft', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523862, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100060', 'abnormal regenerating tissue', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523863, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107259', 'abnormal animal-vegetal axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523864, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100258', 'abnormal organ part', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523865, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100531', 'abnormal proliferative region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523866, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107325', 'abnormal adult thrombocyte', 0.41935483870967744, 5.574066539846944, 1.5288923359002506, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(523867, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100218', 'abnormal epithelial cell', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523868, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101220', 'abnormal centriole', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523869, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100626', 'abnormal primordial germ cell', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523870, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141276', 'decreased surface breathing', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523871, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107265', 'abnormal posterior side', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523872, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107267', 'abnormal ventral side', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523873, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100402', 'abnormal zeugopod', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523874, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100573', 'abnormal extraembryonic structure', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523875, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100416', 'abnormal ligament', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523876, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100232', 'abnormal lymphatic system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523877, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100547', 'abnormal blastomere V2', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523878, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101347', 'abnormal hindlimb region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523879, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101078', 'abnormal mucous gland', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523880, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107269', 'abnormal right side', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523881, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101467', 'abnormal alkali secreting cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523882, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100104', 'abnormal embryonic structure', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523883, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100991', 'abnormal iliac process primordium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523884, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101570', 'abnormal forelimb region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523885, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100900', 'abnormal angioblast', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523886, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100394', 'abnormal marginal zone', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523887, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100295', 'abnormal extracellular matrix', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523888, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141718', 'abnormal posterior notochord', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523889, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0131675', 'abnormal spindle microtubule', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523890, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100458', 'abnormal autopod', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523891, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101503', 'abnormal organ cortex', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523892, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0115758', 'abnormally decreased mobility of melanoblast', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523893, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100162', 'abnormal presumptive rhombomere', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523894, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141715', 'abnormal septum', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523895, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100704', 'abnormal Merkel cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523896, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141265', 'abnormal escape behavior', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523897, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141796', 'abnormal demethylation', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(523898, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101575', 'abnormal vitelline membrane', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523899, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101405', 'abnormal ring structure', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523900, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0131723', 'abnormal pathway-restricted SMAD protein phosphorylation', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523901, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107288', 'abnormal larval alimentary system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523902, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141743', 'abnormal chemical homeostasis within a tissue', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523903, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141787', 'abnormal hormone metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(523904, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101461', 'abnormal sperm entry point', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523905, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100823', 'abnormal blood', 0.5416666666666666, 5.574066539846944, 1.737609289344729, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(523906, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100285', 'abnormal progenitor cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523907, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0142056', 'abnormal main body axis', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523908, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101472', 'abnormal zygote cortex', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523909, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101221', 'abnormal larval immune system', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523910, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100545', 'abnormal male organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523911, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100754', 'abnormal electrically active cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523912, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101362', 'abnormal vegetal cortex', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523913, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100852', 'abnormal interdigital region', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523914, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101174', 'abnormal articular system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523915, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101241', 'abnormal nucleate erythrocyte', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523916, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101168', 'abnormal circulating cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523917, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101113', 'abnormal stage IV oocyte', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523918, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100003', 'abnormal organism subdivision', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523919, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101326', 'abnormal cementoblast', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523920, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100673', 'abnormal anterior dorsal lateral plate region', 0.41935483870967744, 5.574066539846944, 1.5288923359002506, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(523921, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101484', 'abnormal bone marrow', 0.43333333333333335, 5.574066539846944, 1.5541649957239663, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(523922, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0131725', 'abnormal phosphorylation of RNA polymerase II C-terminal domain', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523923, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101072', 'abnormal mitochondrial cloud', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523924, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100643', 'abnormal thoracic region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523925, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100745', 'abnormal anterior lymph sac', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523926, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101451', 'abnormal dorsal lymph space', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523927, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100344', 'abnormal portion of organism substance', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523928, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100465', 'abnormal skeletal system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523929, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100807', 'abnormal matrix-based tissue', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523930, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100152', 'abnormal alimentary system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523931, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101311', 'abnormal bottle cell', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523932, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101212', 'abnormal glomeral mesenchyme', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523933, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101569', 'abnormal activin-induced ectoderm', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523934, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100899', 'abnormal secondary spermatogonium', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523935, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101023', 'abnormal ultimobranchial body', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523936, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141738', 'abnormal carbon dioxide homeostasis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523937, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0142051', 'abnormal cerebrospinal fluid', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523938, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100587', 'abnormal vestibuloauditory system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523939, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141272', 'absent surface breathing', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523940, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141792', 'abnormal small molecule metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(523941, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107285', 'abnormal flexural organ', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523942, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100151', 'abnormal primordium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523943, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107270', 'abnormal proximal-distal axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523944, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100887', 'abnormal right-dorsal blastomere', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523945, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100429', 'abnormal spermatid', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523946, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101283', 'abnormal left-ventral blastomere', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523947, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107323', 'abnormal thrombocyte', 0.43333333333333335, 5.574066539846944, 1.5541649957239663, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(523948, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100610', 'abnormal appendage', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523949, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101202', 'abnormal thymus', 0.41935483870967744, 5.574066539846944, 1.5288923359002506, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(523950, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107271', 'abnormal apical region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523951, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:00000000', 'Xenopus phenotype', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523952, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101468', 'abnormal stage I oocyte', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523953, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141271', 'increased surface breathing', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523954, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101110', 'abnormal cell-free extract', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523955, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101132', 'abnormal apoptotic cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523956, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100667', 'abnormal vegetal yolk mass', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523957, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100225', 'abnormal endocrine system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523958, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100006', 'abnormal anatomical structure', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523959, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100108', 'abnormal cell part', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523960, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101200', 'abnormal joint region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523961, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100917', 'abnormal stage III oocyte', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523962, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100307', 'abnormal blastomere', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523963, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101378', 'abnormal blastomere D1', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523964, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100114', 'abnormal peripheral nervous system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523965, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101074', 'abnormal germinal vesicle', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523966, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101240', 'abnormal ciliated non-epidermal cell', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523967, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100014', 'abnormal tissue', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523968, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100762', 'abnormal intersomitic region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523969, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101237', 'abnormal mucus secreting cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523970, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0131691', 'abnormal molecular function', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523971, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101157', 'abnormal female organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523972, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141791', 'abnormal primary metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(523973, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100427', 'abnormal olfactory system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523974, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141770', 'abnormal urate homeostasis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523975, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107263', 'abnormal anatomical side', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523976, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100902', 'abnormal spermatocyte', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523977, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100856', 'abnormal simple organ', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523978, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101188', 'abnormal posterior ventral blood island', 0.4642857142857143, 5.574066539846944, 1.6087136056268494, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(523979, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101107', 'abnormal erythroid cell', 0.5, 5.574066539846944, 1.6694410052240456, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(523980, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107266', 'abnormal dorsal side', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523981, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100728', 'abnormal cell condensation', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523982, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100976', 'abnormal multiciliated cell', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523983, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0131667', 'abnormal actin cytoskeleton', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523984, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100691', 'abnormal keratin accumulating cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523985, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101056', 'abnormal anterior ventral blood island', 0.4642857142857143, 5.574066539846944, 1.6087136056268494, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(523986, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100251', 'abnormal proteinaceous extracellular matrix', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523987, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100715', 'abnormal ciliated cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523988, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101176', 'abnormal non-ciliated epithelial cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523989, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100477', 'abnormal pericyte', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523990, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100784', 'abnormal left blastomere', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(523991, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100023', 'abnormal mesenchyme', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523992, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107284', 'abnormal migrating myoblast', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(523993, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101096', 'abnormal tendon', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(523994, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100172', 'abnormal stem cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(523995, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0116434', 'abnormal biological process', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(523996, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100004', 'abnormal cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(523997, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107276', 'abnormal dorsal region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(523998, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101366', 'abnormal morula cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(523999, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100915', 'abnormal dermal system', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524000, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100585', 'abnormal elastica externa', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524001, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100025', 'abnormal oocyte', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(524002, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141714', 'abnormal anterior notochord', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524003, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0131677', 'abnormal actin filament', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524004, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0115512', 'abnormally semi-erect whole organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524005, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101411', 'abnormal marginal zone (sensu neural)', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524006, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100907', 'abnormal cytoplasm', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(524007, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107312', 'abnormal filopodium', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(524008, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100423', 'abnormal process', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524009, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101513', 'abnormal basal body', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(524010, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100293', 'abnormal duct', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524011, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101498', 'abnormal stage II oocyte', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524012, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100317', 'abnormal respiratory system', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(524013, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100062', 'abnormal anatomical space', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524014, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100642', 'abnormal gustatory system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524015, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101587', 'abnormal hemangioblast', 0.5, 5.574066539846944, 1.6694410052240456, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(524016, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100268', 'abnormal circulatory system', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524017, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0131669', 'abnormal Roux spot', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524018, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100503', 'abnormal blastomere D2', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524019, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100070', 'abnormal anatomical system', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524020, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100724', 'abnormal kinetochore', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(524021, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0115391', 'abnormally undifferentiated alimentary system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524022, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107278', 'abnormal medial region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524023, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141263', 'abnormal visually guided collision avoidance behavior', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524024, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100010', 'abnormal multicellular anatomical structure', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524025, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141778', 'abnormal biosynthetic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524026, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100791', 'abnormal multiciliated cell precursor', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(524027, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100802', 'abnormal exocrine cell', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(524028, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107261', 'abnormal dorsal-ventral axis', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524029, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100415', 'abnormal secretory epithelial cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524030, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141786', 'abnormal pigment metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524031, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107272', 'abnormal axial region', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524032, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101136', 'abnormal ooplasm', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524033, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101302', 'abnormal subcortical cytoplasm', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524034, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141777', 'abnormal catabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524035, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141841', 'abnormality of whole organism mass', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524036, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100308', 'abnormal early embryonic cell', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(524037, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107258', 'abnormal anatomical axis', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524038, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101406', 'abnormal cleavage furrow', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524039, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0116494', 'absent biological process', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524040, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107324', 'abnormal embryonic thrombocyte', 0.41935483870967744, 5.574066539846944, 1.5288923359002506, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(524041, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141264', 'abnormal schooling behavior', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524042, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100616', 'abnormal ventral blood island', 0.48148148148148145, 5.574066539846944, 1.6382337487311942, 'HP:0001871', 'Abnormality of blood and blood-forming tissues'),
(524043, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100638', 'abnormal polar body', 0.4782608695652174, 1.8210412618256888, 0.9332377925239069, 'HP:0000118', 'Phenotypic abnormality'),
(524044, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0131666', 'abnormal adherens junction', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(524045, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100551', 'abnormal oocyte cortex', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524046, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0125135', 'absent blood', 0.40625, 5.574066539846944, 1.5048137864243607, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(524047, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101141', 'abnormal Keller explant', 0.47368421052631576, 1.706362323152461, 0.8990422069704646, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524048, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100069', 'abnormal urinary system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524049, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100481', 'abnormal anatomical line', 0.5, 1.706362323152461, 0.9236780616514774, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524050, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0102004', 'abnormal hematological system morphology', 0.41935483870967744, 5.574066539846944, 1.5288923359002506, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(524051, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0101519', 'abnormal hypobranchial placode', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524052, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100231', 'abnormal compound organ', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524053, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0141794', 'abnormal prosthetic group metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524054, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107264', 'abnormal anterior side', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524055, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100372', 'abnormal hematological system', 0.5909090909090909, 5.574066539846944, 1.8148737123358583, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(524056, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0100192', 'abnormal epithelium', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524057, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0115509', 'abnormally semi-viable whole organism', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524058, 'HP:0005520', 'Chronic disseminated intravascular coagulation', 'XPO:0107339', 'abnormal yolk platelet', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524059, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'XPO:0101029', 'abnormal right spleen primordium', 0.41935483870967744, 5.64885357140806, 1.5391147060347428, 'HP:0002715', 'Abnormality of the immune system'),
(524060, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'XPO:0100004', 'abnormal cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524061, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'XPO:0101518', 'abnormal B cell', 0.40625, 5.64885357140806, 1.5148751642906173, 'HP:0002715', 'Abnormality of the immune system'),
(524062, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'XPO:0100581', 'abnormal immune system', 0.48148148148148145, 5.64885357140806, 1.6491871895674883, 'HP:0002715', 'Abnormality of the immune system'),
(524063, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'XPO:0100745', 'abnormal anterior lymph sac', 0.43333333333333335, 5.64885357140806, 1.5645563421015427, 'HP:0002715', 'Abnormality of the immune system'),
(524064, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'XPO:0101083', 'abnormal T cell', 0.40625, 5.64885357140806, 1.5148751642906173, 'HP:0002715', 'Abnormality of the immune system'),
(524065, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'XPO:0100540', 'abnormal left lymph heart', 0.40625, 5.64885357140806, 1.5148751642906173, 'HP:0002715', 'Abnormality of the immune system'),
(524066, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'XPO:0100242', 'abnormal right lymph heart', 0.40625, 5.64885357140806, 1.5148751642906173, 'HP:0002715', 'Abnormality of the immune system'),
(524067, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'XPO:0100232', 'abnormal lymphatic system', 0.48148148148148145, 5.64885357140806, 1.6491871895674883, 'HP:0002715', 'Abnormality of the immune system'),
(524068, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'XPO:0141497', 'abnormal lymphoblast', 0.41935483870967744, 5.64885357140806, 1.5391147060347428, 'HP:0002715', 'Abnormality of the immune system'),
(524069, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'XPO:0101451', 'abnormal dorsal lymph space', 0.4482758620689655, 5.64885357140806, 1.5913028324062968, 'HP:0002715', 'Abnormality of the immune system'),
(524070, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'XPO:0100599', 'abnormal adult immune system', 0.4642857142857143, 5.64885357140806, 1.6194696710023933, 'HP:0002715', 'Abnormality of the immune system'),
(524071, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'XPO:0101221', 'abnormal larval immune system', 0.4642857142857143, 5.64885357140806, 1.6194696710023933, 'HP:0002715', 'Abnormality of the immune system'),
(524072, 'HP:0034137', 'Anti-contactin-1 antibody positivity', 'XPO:0100449', 'abnormal lymphocyte', 0.41935483870967744, 5.64885357140806, 1.5391147060347428, 'HP:0002715', 'Abnormality of the immune system'),
(524073, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0103634', 'abnormally increased number of forelimb digit', 0.475, 7.774297771301195, 1.9216637170348165, 'HP:0005918', 'Abnormal finger phalanx morphology'),
(524074, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0141556', 'abnormal forelimb digit morphology in the regenerating forelimb', 0.415929203539823, 7.492661022682715, 1.7653375120804229, 'HP:0001167', 'Abnormal finger morphology'),
(524075, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0102787', 'abnormal forelimb digit 5 morphology', 0.43119266055045874, 7.492661022682715, 1.7974371869340195, 'HP:0001167', 'Abnormal finger morphology'),
(524076, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0103468', 'bifurcated forelimb digit 5', 0.4180327868852459, 8.968875860151847, 1.9363068380417097, 'UPHENO:0082301', 'shape anatomical entity in pectoral complex'),
(524077, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0115786', 'duplicated forelimb digit 2 in regenerating forelimb', 0.4351145038167939, 7.774297771301195, 1.839214429391996, 'HP:0005918', 'Abnormal finger phalanx morphology'),
(524078, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0102598', 'abnormal forelimb digit 3 morphology', 0.43119266055045874, 7.492661022682715, 1.7974371869340195, 'HP:0001167', 'Abnormal finger morphology'),
(524079, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0103467', 'bifurcated forelimb digit 4', 0.4180327868852459, 8.968875860151847, 1.9363068380417097, 'UPHENO:0082301', 'shape anatomical entity in pectoral complex'),
(524080, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0133358', 'fused forelimb digits', 0.4051724137931034, 7.492661022682715, 1.7423603393941962, 'HP:0001167', 'Abnormal finger morphology'),
(524081, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0102529', 'abnormal forelimb digit 4 morphology', 0.43119266055045874, 7.492661022682715, 1.7974371869340195, 'HP:0001167', 'Abnormal finger morphology'),
(524082, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0103466', 'bifurcated forelimb digit 3', 0.4180327868852459, 8.968875860151847, 1.9363068380417097, 'UPHENO:0082301', 'shape anatomical entity in pectoral complex'),
(524083, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0115787', 'duplicated forelimb digit 3 in regenerating forelimb', 0.4351145038167939, 7.774297771301195, 1.839214429391996, 'HP:0005918', 'Abnormal finger phalanx morphology'),
(524084, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0102214', 'abnormal forelimb digit morphology', 0.4392523364485981, 7.492661022682715, 1.8141578929163595, 'HP:0001167', 'Abnormal finger morphology'),
(524085, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0140219', 'abnormally necrotic forelimb digit', 0.40869565217391307, 7.492661022682715, 1.7499194219115835, 'HP:0001167', 'Abnormal finger morphology'),
(524086, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0103465', 'bifurcated forelimb digit 2', 0.4180327868852459, 8.968875860151847, 1.9363068380417097, 'UPHENO:0082301', 'shape anatomical entity in pectoral complex'),
(524087, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0102746', 'abnormal forelimb digit 2 morphology', 0.43119266055045874, 7.492661022682715, 1.7974371869340195, 'HP:0001167', 'Abnormal finger morphology'),
(524088, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0103755', 'increased size of the forelimb digit', 0.4017094017094017, 7.492661022682715, 1.734898376457027, 'HP:0001167', 'Abnormal finger morphology'),
(524089, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0103609', 'abnormally increased number of forelimb digit in the regenerating forelimb', 0.4523809523809524, 7.774297771301195, 1.875351761636827, 'HP:0005918', 'Abnormal finger phalanx morphology'),
(524090, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0115789', 'duplicated forelimb digit 5 in regenerating forelimb', 0.4351145038167939, 7.774297771301195, 1.839214429391996, 'HP:0005918', 'Abnormal finger phalanx morphology'),
(524091, 'HP:0009853', 'Bullet-shaped proximal phalanges of the hand', 'XPO:0115788', 'duplicated forelimb digit 4 in regenerating forelimb', 0.4351145038167939, 7.774297771301195, 1.839214429391996, 'HP:0005918', 'Abnormal finger phalanx morphology'),
(524092, 'HP:0000619', 'Impaired convergence', 'XPO:0101173', 'abnormal retinal layer', 0.4107142857142857, 6.02624522851634, 1.5732339319278652, 'HP:0000478', 'Abnormality of the eye'),
(524093, 'HP:0009298', 'Aplasia of the proximal phalanx of the 4th finger', 'XPO:0103280', 'absent forelimb digit 3', 0.4642857142857143, 12.234769920124881, 2.383365035299157, 'UPHENO:0009382', 'absent manual digit'),
(524094, 'HP:0009298', 'Aplasia of the proximal phalanx of the 4th finger', 'XPO:0103279', 'absent forelimb digit 2', 0.4642857142857143, 12.234769920124881, 2.383365035299157, 'UPHENO:0009382', 'absent manual digit'),
(524095, 'HP:0009298', 'Aplasia of the proximal phalanx of the 4th finger', 'XPO:0103282', 'absent forelimb digit 5', 0.4642857142857143, 12.234769920124881, 2.383365035299157, 'UPHENO:0009382', 'absent manual digit'),
(524096, 'HP:0009298', 'Aplasia of the proximal phalanx of the 4th finger', 'XPO:0125257', 'absent forelimb digit', 0.4744525547445255, 12.234769920124881, 2.409318958816936, 'UPHENO:0009382', 'absent manual digit'),
(524097, 'HP:0009298', 'Aplasia of the proximal phalanx of the 4th finger', 'XPO:0103281', 'absent forelimb digit 4', 0.4642857142857143, 12.234769920124881, 2.383365035299157, 'UPHENO:0009382', 'absent manual digit'),
(524098, 'HP:0009298', 'Aplasia of the proximal phalanx of the 4th finger', 'XPO:0103634', 'abnormally increased number of forelimb digit', 0.4041095890410959, 7.774297771301195, 1.7724751838724382, 'HP:0005918', 'Abnormal finger phalanx morphology'),
(524099, 'HP:0031260', 'Triangular tibia', 'XPO:0141567', 'abnormal joint region morphology in the femur', 0.4148936170212766, 7.61213700143767, 1.7771401334132233, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(524100, 'HP:0031260', 'Triangular tibia', 'XPO:0141208', 'abnormally necrotic digit-joint region', 0.40540540540540543, 5.914846961127896, 1.5485189473128784, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(524101, 'HP:0031260', 'Triangular tibia', 'XPO:0102566', 'abnormal claw primordium morphology', 0.4069767441860465, 7.61213700143767, 1.7601030461717968, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(524102, 'HP:0031260', 'Triangular tibia', 'XPO:0101810', 'abnormal digit morphology', 0.42857142857142855, 5.914846961127896, 1.5921477355798221, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(524103, 'HP:0031260', 'Triangular tibia', 'XPO:0103008', 'abnormal iliac process morphology', 0.42857142857142855, 7.61213700143767, 1.806196121462886, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(524104, 'HP:0031260', 'Triangular tibia', 'XPO:0101859', 'abnormal hindlimb skeleton morphology', 0.4027777777777778, 7.61213700143767, 1.7509996075325265, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(524105, 'HP:0031260', 'Triangular tibia', 'XPO:0140858', 'abnormally necrotic iliac process', 0.4090909090909091, 7.61213700143767, 1.764668820499383, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(524106, 'HP:0031260', 'Triangular tibia', 'XPO:0102880', 'abnormal digit-joint region morphology', 0.42857142857142855, 5.914846961127896, 1.5921477355798221, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(524107, 'HP:0031260', 'Triangular tibia', 'XPO:0100178', 'abnormal digit', 0.41935483870967744, 5.802924133159483, 1.5599629206829213, 'UPHENO:0076727', 'abnormal limb bone morphology'),
(524108, 'HP:0031260', 'Triangular tibia', 'XPO:0101809', 'abnormal hindlimb digit morphology', 0.40229885057471265, 7.61213700143767, 1.7499582755299095, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(524109, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100422', 'abnormal notochord', 0.4444444444444444, 3.9037819259951223, 1.3171993734173904, 'HP:0033127', 'Abnormality of the musculoskeletal system'),
(524110, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100852', 'abnormal interdigital region', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524111, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101498', 'abnormal stage II oocyte', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524112, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100802', 'abnormal exocrine cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524113, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101264', 'abnormal mitotic spindle', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524114, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100768', 'abnormal pectoral girdle', 0.40476190476190477, 6.895202660022325, 1.6706032929423995, 'HP:0011805', 'Abnormal skeletal muscle morphology'),
(524115, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100377', 'abnormal connective tissue', 0.46153846153846156, 3.9037819259951223, 1.3422911399191462, 'HP:0033127', 'Abnormality of the musculoskeletal system'),
(524116, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0107261', 'abnormal dorsal-ventral axis', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524117, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100032', 'abnormal nervous system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524118, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100437', 'abnormal proepicardium', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524119, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101174', 'abnormal articular system', 0.42857142857142855, 3.9037819259951223, 1.293464107292913, 'HP:0033127', 'Abnormality of the musculoskeletal system'),
(524120, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101569', 'abnormal activin-induced ectoderm', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524121, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100285', 'abnormal progenitor cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524122, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101061', 'abnormal plasma membrane', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524123, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0103353', 'decreased size of the muscle', 0.40476190476190477, 6.895202660022325, 1.6706032929423995, 'HP:0011805', 'Abnormal skeletal muscle morphology'),
(524124, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101326', 'abnormal cementoblast', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524125, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100084', 'abnormal anatomical group', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524126, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100062', 'abnormal anatomical space', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524127, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101435', 'abnormal paracrine cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524128, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0102113', 'abnormal anatomical line morphology', 0.4166666666666667, 2.485033483301678, 1.0175611126818702, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(524129, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100010', 'abnormal multicellular anatomical structure', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524130, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101480', 'abnormal stage V oocyte', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524131, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101467', 'abnormal alkali secreting cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524132, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101113', 'abnormal stage IV oocyte', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524133, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100746', 'abnormal smooth muscle', 0.4827586206896552, 5.968280811662945, 1.6974212831607063, 'UPHENO:0002816', 'abnormal musculature'),
(524134, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100317', 'abnormal respiratory system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524135, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101004', 'abnormal acid secreting cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524136, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0142057', 'abnormal desmosome', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524137, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100638', 'abnormal polar body', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524138, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101713', 'abnormal anatomical entity in vitro morphology', 0.4166666666666667, 2.485033483301678, 1.0175611126818702, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(524139, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100674', 'abnormal secondary oogonium', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524140, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0131685', 'abnormal cortical actin cytoskeleton', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524141, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100081', 'abnormal anatomical entity in vitro', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524142, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100626', 'abnormal primordial germ cell', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524143, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101373', 'abnormal oxygen accumulating cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524144, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101157', 'abnormal female organism', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524145, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100026', 'abnormal germ cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524146, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0102228', 'abnormal myocyte morphology', 0.425, 6.895202660022325, 1.7118589692230748, 'HP:0011805', 'Abnormal skeletal muscle morphology'),
(524147, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100956', 'abnormal centrosome', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524148, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100416', 'abnormal ligament', 0.42857142857142855, 3.9037819259951223, 1.293464107292913, 'HP:0033127', 'Abnormality of the musculoskeletal system'),
(524149, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0115508', 'abnormally peramorphic growth of whole organism', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524150, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100429', 'abnormal spermatid', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524151, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101535', 'abnormal absorptive cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524152, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100308', 'abnormal early embryonic cell', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524153, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100004', 'abnormal cell', 0.4583333333333333, 1.8210412618256888, 0.9135884804823818, 'HP:0000118', 'Phenotypic abnormality'),
(524154, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100417', 'abnormal dense regular connective tissue', 0.4444444444444444, 3.9037819259951223, 1.3171993734173904, 'HP:0033127', 'Abnormality of the musculoskeletal system'),
(524155, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100969', 'abnormal disaggregated/reaggregated ectoderm treated with activin', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524156, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0141284', 'abnormal myofibril morphology', 0.425, 6.895202660022325, 1.7118589692230748, 'HP:0011805', 'Abnormal skeletal muscle morphology'),
(524157, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100721', 'abnormal centromere', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524158, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100894', 'abnormal nucleus', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524159, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0141718', 'abnormal posterior notochord', 0.42857142857142855, 3.9037819259951223, 1.293464107292913, 'HP:0033127', 'Abnormality of the musculoskeletal system'),
(524160, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0141776', 'abnormal metabolic process', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524161, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100307', 'abnormal blastomere', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524162, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100392', 'abnormal cilium', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524163, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100344', 'abnormal portion of organism substance', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524164, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0115512', 'abnormally semi-erect whole organism', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524165, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100724', 'abnormal kinetochore', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524166, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101096', 'abnormal tendon', 0.42857142857142855, 3.9037819259951223, 1.293464107292913, 'HP:0033127', 'Abnormality of the musculoskeletal system'),
(524167, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101976', 'abnormal portion of organism substance morphology', 0.4166666666666667, 2.485033483301678, 1.0175611126818702, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(524168, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101448', 'abnormal myelin accumulating cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524169, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0131675', 'abnormal spindle microtubule', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524170, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100172', 'abnormal stem cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524171, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0141499', 'abnormal tadpole', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524172, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100202', 'abnormal embryo', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524173, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101220', 'abnormal centriole', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524174, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100225', 'abnormal endocrine system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524175, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100573', 'abnormal extraembryonic structure', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524176, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100907', 'abnormal cytoplasm', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524177, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0139779', 'abnormally necrotic muscle', 0.425, 6.895202660022325, 1.7118589692230748, 'HP:0011805', 'Abnormal skeletal muscle morphology'),
(524178, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0107258', 'abnormal anatomical axis', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524179, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101132', 'abnormal apoptotic cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524180, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100465', 'abnormal skeletal system', 0.4444444444444444, 3.9037819259951223, 1.3171993734173904, 'HP:0033127', 'Abnormality of the musculoskeletal system'),
(524181, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100006', 'abnormal anatomical structure', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524182, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100232', 'abnormal lymphatic system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524183, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0115509', 'abnormally semi-viable whole organism', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524184, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100108', 'abnormal cell part', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524185, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101461', 'abnormal sperm entry point', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524186, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0131677', 'abnormal actin filament', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524187, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101240', 'abnormal ciliated non-epidermal cell', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524188, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0107262', 'abnormal left-right axis', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524189, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101109', 'abnormal egg cell-free extract', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524190, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101221', 'abnormal larval immune system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524191, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100691', 'abnormal keratin accumulating cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524192, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100581', 'abnormal immune system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524193, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100031', 'abnormal central nervous system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524194, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0131667', 'abnormal actin cytoskeleton', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524195, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0103098', 'abnormal secondary myofiber morphology', 0.425, 6.895202660022325, 1.7118589692230748, 'HP:0011805', 'Abnormal skeletal muscle morphology'),
(524196, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101732', 'abnormal muscle morphology', 0.4857142857142857, 6.895202660022325, 1.8300542163739266, 'HP:0011805', 'Abnormal skeletal muscle morphology'),
(524197, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101071', 'abnormal endoplasmic reticulum', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524198, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100372', 'abnormal hematological system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524199, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101468', 'abnormal stage I oocyte', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524200, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101409', 'abnormal perivitelline space', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524201, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100728', 'abnormal cell condensation', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524202, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0107312', 'abnormal filopodium', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524203, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100176', 'abnormal stage VI oocyte', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524204, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100644', 'abnormal smooth muscle myocyte', 0.4117647058823529, 5.968280811662945, 1.5676502776568768, 'UPHENO:0002816', 'abnormal musculature'),
(524205, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100976', 'abnormal multiciliated cell', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524206, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100549', 'abnormal mitotic cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524207, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100715', 'abnormal ciliated cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524208, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100640', 'abnormal notochordal sheath', 0.42857142857142855, 3.9037819259951223, 1.293464107292913, 'HP:0033127', 'Abnormality of the musculoskeletal system'),
(524209, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0131655', 'abnormal myofibril', 0.4117647058823529, 5.968280811662945, 1.5676502776568768, 'UPHENO:0002816', 'abnormal musculature'),
(524210, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0141714', 'abnormal anterior notochord', 0.42857142857142855, 3.9037819259951223, 1.293464107292913, 'HP:0033127', 'Abnormality of the musculoskeletal system'),
(524211, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100501', 'abnormal urogenital system', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524212, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100546', 'abnormal whole organism', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524213, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0107259', 'abnormal animal-vegetal axis', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524214, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100902', 'abnormal spermatocyte', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524215, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100791', 'abnormal multiciliated cell precursor', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524216, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100688', 'abnormal adipose tissue', 0.4444444444444444, 3.9037819259951223, 1.3171993734173904, 'HP:0033127', 'Abnormality of the musculoskeletal system'),
(524217, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101466', 'abnormal secondary myofiber', 0.4375, 5.968280811662945, 1.6158969197020392, 'UPHENO:0002816', 'abnormal musculature'),
(524218, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0107253', 'abnormal enteric nervous system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524219, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101228', 'abnormal mesenchymal stem cell', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524220, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0103113', 'abnormal skeletal muscle satellite cell morphology', 0.4146341463414634, 6.895202660022325, 1.6908537691916898, 'HP:0011805', 'Abnormal skeletal muscle morphology'),
(524221, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100025', 'abnormal oocyte', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524222, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100100', 'abnormal muscle', 0.5, 5.968280811662945, 1.7274664702481124, 'UPHENO:0002816', 'abnormal musculature'),
(524223, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100274', 'abnormal sensory system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524224, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101333', 'abnormal barrier epithelial cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524225, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100839', 'abnormal skeletal myocyte', 0.4117647058823529, 5.968280811662945, 1.5676502776568768, 'UPHENO:0002816', 'abnormal musculature'),
(524226, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101547', 'abnormal lampbrush chromosome', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524227, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101907', 'abnormal skeletal muscle morphology', 0.4594594594594595, 6.895202660022325, 1.7799062017525769, 'HP:0011805', 'Abnormal skeletal muscle morphology'),
(524228, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101153', 'abnormal musculature of face', 0.40476190476190477, 6.895202660022325, 1.6706032929423995, 'HP:0011805', 'Abnormal skeletal muscle morphology'),
(524229, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0107285', 'abnormal flexural organ', 0.42857142857142855, 3.9037819259951223, 1.293464107292913, 'HP:0033127', 'Abnormality of the musculoskeletal system'),
(524230, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101481', 'abnormal skeletal muscle satellite cell', 0.42424242424242425, 5.968280811662945, 1.591225288920281, 'UPHENO:0002816', 'abnormal musculature'),
(524231, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100533', 'abnormal melanoblast', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524232, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0141294', 'abnormal sarcomere morphology', 0.4146341463414634, 6.895202660022325, 1.6908537691916898, 'HP:0011805', 'Abnormal skeletal muscle morphology'),
(524233, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101241', 'abnormal nucleate erythrocyte', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524234, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100754', 'abnormal electrically active cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524235, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100899', 'abnormal secondary spermatogonium', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524236, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101297', 'abnormal barrier cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524237, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100585', 'abnormal elastica externa', 0.46153846153846156, 3.9037819259951223, 1.3422911399191462, 'HP:0033127', 'Abnormality of the musculoskeletal system'),
(524238, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100888', 'abnormal microtubule', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524239, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100704', 'abnormal Merkel cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524240, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0107260', 'abnormal anterior-posterior axis', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524241, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100258', 'abnormal organ part', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524242, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101141', 'abnormal Keller explant', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524243, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100477', 'abnormal pericyte', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524244, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0103736', 'increased size of the muscle', 0.40476190476190477, 6.895202660022325, 1.6706032929423995, 'HP:0011805', 'Abnormal skeletal muscle morphology'),
(524245, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101638', 'abnormal anatomical structure morphology', 0.4166666666666667, 2.485033483301678, 1.0175611126818702, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(524246, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101237', 'abnormal mucus secreting cell', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524247, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100275', 'abnormal skeletal muscle', 0.4827586206896552, 5.968280811662945, 1.6974212831607063, 'UPHENO:0002816', 'abnormal musculature'),
(524248, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100386', 'abnormal limb', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524249, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101366', 'abnormal morula cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524250, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100917', 'abnormal stage III oocyte', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524251, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100545', 'abnormal male organism', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524252, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100378', 'abnormal perichondrium', 0.41379310344827586, 3.9037819259951223, 1.270967363209146, 'HP:0033127', 'Abnormality of the musculoskeletal system'),
(524253, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0102378', 'abnormal smooth muscle morphology', 0.4473684210526316, 6.895202660022325, 1.7563302442456807, 'HP:0011805', 'Abnormal skeletal muscle morphology'),
(524254, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100289', 'abnormal chondroblast', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524255, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100481', 'abnormal anatomical line', 0.45, 1.706362323152461, 0.8762779498644294, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524256, 'HP:0012233', 'Intramuscular hematoma', 'XPO:00000000', 'Xenopus phenotype', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524257, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100423', 'abnormal process', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524258, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101513', 'abnormal basal body', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524259, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0141315', 'abnormal anatomical region', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524260, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101472', 'abnormal zygote cortex', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524261, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0107270', 'abnormal proximal-distal axis', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524262, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100515', 'abnormal somatic stem cell', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524263, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100599', 'abnormal adult immune system', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524264, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0101110', 'abnormal cell-free extract', 0.42857142857142855, 1.706362323152461, 0.8551597151958877, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524265, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100239', 'abnormal acellular anatomical structure', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524266, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0141307', 'abnormal M band morphology', 0.40476190476190477, 6.895202660022325, 1.6706032929423995, 'HP:0011805', 'Abnormal skeletal muscle morphology'),
(524267, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100574', 'abnormal gastrula cell', 0.4074074074074074, 1.8210412618256888, 0.861339479684008, 'HP:0000118', 'Phenotypic abnormality'),
(524268, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100653', 'abnormal myoblast', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524269, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0107284', 'abnormal migrating myoblast', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524270, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100935', 'abnormal skeleton', 0.41379310344827586, 3.9037819259951223, 1.270967363209146, 'HP:0033127', 'Abnormality of the musculoskeletal system'),
(524271, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0115505', 'dead whole organism', 0.4090909090909091, 1.706362323152461, 0.8354982429765582, 'UPHENO:0002536', 'abnormal anatomical entity'),
(524272, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0131666', 'abnormal adherens junction', 0.4230769230769231, 1.8210412618256888, 0.8777474203034321, 'HP:0000118', 'Phenotypic abnormality'),
(524273, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100596', 'abnormal myocyte', 0.4375, 5.968280811662945, 1.6158969197020392, 'UPHENO:0002816', 'abnormal musculature'),
(524274, 'HP:0012233', 'Intramuscular hematoma', 'XPO:0100337', 'abnormal zygote', 0.44, 1.8210412618256888, 0.8951302448265857, 'HP:0000118', 'Phenotypic abnormality'),
(524275, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0107270', 'abnormal proximal-distal axis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524276, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101435', 'abnormal paracrine cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524277, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101451', 'abnormal dorsal lymph space', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524278, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100277', 'abnormal blastocoel', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524279, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100477', 'abnormal pericyte', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524280, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101498', 'abnormal stage II oocyte', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524281, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100289', 'abnormal chondroblast', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524282, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100546', 'abnormal whole organism', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524283, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131745', 'abnormal axis elongation', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524284, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0115512', 'abnormally semi-erect whole organism', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524285, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131729', 'abnormal regulation of growth rate', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524286, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100902', 'abnormal spermatocyte', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524287, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100704', 'abnormal Merkel cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524288, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100791', 'abnormal multiciliated cell precursor', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524289, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101004', 'abnormal acid secreting cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524290, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100989', 'abnormal right blastomere', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524291, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101468', 'abnormal stage I oocyte', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524292, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141903', 'abnormal inositol phosphate metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524293, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100465', 'abnormal skeletal system', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524294, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100344', 'abnormal portion of organism substance', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524295, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141738', 'abnormal carbon dioxide homeostasis', 0.5333333333333333, 1.4755025719078136, 0.8870934026456857, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524296, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100917', 'abnormal stage III oocyte', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524297, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100176', 'abnormal stage VI oocyte', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524298, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100031', 'abnormal central nervous system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524299, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101110', 'abnormal cell-free extract', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524300, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141852', 'abnormal glucose metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524301, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101283', 'abnormal left-ventral blastomere', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524302, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0107259', 'abnormal animal-vegetal axis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524303, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141776', 'abnormal metabolic process', 0.6111111111111112, 4.758907843651163, 1.705350831943106, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524304, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100202', 'abnormal embryo', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524305, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0107312', 'abnormal filopodium', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524306, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101547', 'abnormal lampbrush chromosome', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524307, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141904', 'abnormal glucosamine metabolic process', 0.55, 4.758907843651163, 1.6178378515809735, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524308, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141754', 'abnormal homeostatic process', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524309, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100377', 'abnormal connective tissue', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524310, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101132', 'abnormal apoptotic cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524311, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141809', 'abnormal catalytic activity', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524312, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141264', 'abnormal schooling behavior', 0.5333333333333333, 1.4755025719078136, 0.8870934026456857, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524313, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131667', 'abnormal actin cytoskeleton', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524314, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141877', 'abnormal 2-deoxyribose 1-phosphate metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524315, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100307', 'abnormal blastomere', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524316, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101200', 'abnormal joint region', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524317, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141910', 'abnormal D-ribose metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524318, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131722', 'abnormal determination of left/right symmetry', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524319, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100481', 'abnormal anatomical line', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524320, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101378', 'abnormal blastomere D1', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524321, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100665', 'abnormal egg jelly', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524322, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141787', 'abnormal hormone metabolic process', 0.55, 4.758907843651163, 1.6178378515809735, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524323, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131691', 'abnormal molecular function', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524324, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141915', 'abnormal taurine metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524325, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101141', 'abnormal Keller explant', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524326, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141850', 'abnormal galactose metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524327, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101220', 'abnormal centriole', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524328, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0116434', 'abnormal biological process', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524329, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100724', 'abnormal kinetochore', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524330, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131687', 'abnormal astral microtubule', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524331, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0107339', 'abnormal yolk platelet', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524332, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141499', 'abnormal tadpole', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524333, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100754', 'abnormal electrically active cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524334, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100025', 'abnormal oocyte', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524335, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100009', 'abnormal multi-tissue structure', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524336, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141794', 'abnormal prosthetic group metabolic process', 0.55, 4.758907843651163, 1.6178378515809735, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524337, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141866', 'abnormal dicarboxylic acid metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524338, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141958', 'absent cilium motility in left-right organizer', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524339, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141798', 'abnormal lipid metabolic process', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524340, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101467', 'abnormal alkali secreting cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524341, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100728', 'abnormal cell condensation', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524342, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131744', 'abnormal apical constriction', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524343, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141881', 'abnormal fructose metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524344, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141962', 'absent cilium motility in pronephric kidney', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524345, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100533', 'abnormal melanoblast', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524346, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100587', 'abnormal vestibuloauditory system', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524347, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100643', 'abnormal thoracic region', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524348, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100032', 'abnormal nervous system', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524349, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100205', 'abnormal limb segment', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524350, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141770', 'abnormal urate homeostasis', 0.5333333333333333, 1.4755025719078136, 0.8870934026456857, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524351, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100104', 'abnormal embryonic structure', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524352, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141767', 'abnormal temperature homeostasis', 0.4583333333333333, 4.758907843651163, 1.4768771428276568, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524353, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101389', 'abnormal wedge region', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524354, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101157', 'abnormal female organism', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524355, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100372', 'abnormal hematological system', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524356, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101136', 'abnormal ooplasm', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524357, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141777', 'abnormal catabolic process', 0.55, 4.758907843651163, 1.6178378515809735, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524358, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0107263', 'abnormal anatomical side', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524359, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100295', 'abnormal extracellular matrix', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524360, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101513', 'abnormal basal body', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524361, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131703', 'abnormal cell division', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524362, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131730', 'abnormal regulation of protein folding', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524363, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101264', 'abnormal mitotic spindle', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524364, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100894', 'abnormal nucleus', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524365, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101241', 'abnormal nucleate erythrocyte', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524366, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131675', 'abnormal spindle microtubule', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524367, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131723', 'abnormal pathway-restricted SMAD protein phosphorylation', 0.5333333333333333, 1.4755025719078136, 0.8870934026456857, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524368, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141276', 'decreased surface breathing', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524369, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100437', 'abnormal proepicardium', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524370, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0116429', 'abnormal behavior', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524371, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131725', 'abnormal phosphorylation of RNA polymerase II C-terminal domain', 0.5333333333333333, 1.4755025719078136, 0.8870934026456857, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524372, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141907', 'abnormal putrescine metabolic process', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524373, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101221', 'abnormal larval immune system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524374, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100003', 'abnormal organism subdivision', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524375, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100549', 'abnormal mitotic cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524376, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141908', 'abnormal pyridine metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524377, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141863', 'abnormal lactate metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524378, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141898', 'abnormal maltose metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524379, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100574', 'abnormal gastrula cell', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524380, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141788', 'abnormal hormone biosynthetic process', 0.4583333333333333, 4.758907843651163, 1.4768771428276568, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524381, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141860', 'abnormal malate-aspartate shuttle', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524382, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100232', 'abnormal lymphatic system', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524383, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100386', 'abnormal limb', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524384, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141745', 'abnormal creatinine homeostasis', 0.5333333333333333, 1.4755025719078136, 0.8870934026456857, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524385, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141920', 'abnormal urea metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524386, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101072', 'abnormal mitochondrial cloud', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524387, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141791', 'abnormal primary metabolic process', 0.55, 4.758907843651163, 1.6178378515809735, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524388, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101071', 'abnormal endoplasmic reticulum', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524389, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101347', 'abnormal hindlimb region', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524390, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131740', 'abnormal detection of nodal flow', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524391, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100285', 'abnormal progenitor cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524392, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100599', 'abnormal adult immune system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524393, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101535', 'abnormal absorptive cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524394, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141864', 'abnormal 5-methylcytosine metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524395, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0107278', 'abnormal medial region', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524396, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141859', 'abnormal lactose catabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524397, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141884', 'abnormal phosphagen metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524398, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100956', 'abnormal centrosome', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524399, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100172', 'abnormal stem cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524400, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101326', 'abnormal cementoblast', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524401, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100762', 'abnormal intersomitic region', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524402, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100969', 'abnormal disaggregated/reaggregated ectoderm treated with activin', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524403, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0107271', 'abnormal apical region', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524404, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100688', 'abnormal adipose tissue', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524405, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141790', 'abnormal cellular metabolic process', 0.5238095238095238, 4.758907843651163, 1.5788480773767701, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524406, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141784', 'abnormal cellular hormone metabolic process', 0.5333333333333333, 1.4755025719078136, 0.8870934026456857, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524407, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101409', 'abnormal perivitelline space', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524408, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100258', 'abnormal organ part', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524409, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100028', 'abnormal anatomical cluster', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524410, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101237', 'abnormal mucus secreting cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524411, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141771', 'abnormal urea homeostasis', 0.5333333333333333, 1.4755025719078136, 0.8870934026456857, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524412, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101061', 'abnormal plasma membrane', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524413, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101113', 'abnormal stage IV oocyte', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524414, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100784', 'abnormal left blastomere', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524415, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100515', 'abnormal somatic stem cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524416, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141900', 'abnormal mannose metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524417, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0133340', 'abnormal cell adhesion', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524418, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141792', 'abnormal small molecule metabolic process', 0.55, 4.758907843651163, 1.6178378515809735, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524419, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100823', 'abnormal blood', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524420, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141854', 'abnormal glutathione metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524421, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141781', 'abnormal secondary metabolic process', 0.55, 4.758907843651163, 1.6178378515809735, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524422, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141880', 'abnormal ethanolamine metabolic process', 0.4583333333333333, 4.758907843651163, 1.4768771428276568, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524423, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100274', 'abnormal sensory system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524424, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100691', 'abnormal keratin accumulating cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524425, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100545', 'abnormal male organism', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524426, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0107272', 'abnormal axial region', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524427, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100551', 'abnormal oocyte cortex', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524428, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101302', 'abnormal subcortical cytoplasm', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524429, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141892', 'abnormal inositol metabolic process', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524430, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141796', 'abnormal demethylation', 0.55, 4.758907843651163, 1.6178378515809735, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524431, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101240', 'abnormal ciliated non-epidermal cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524432, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141775', 'abnormal nitrogen compound metabolic process', 0.55, 4.758907843651163, 1.6178378515809735, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524433, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100422', 'abnormal notochord', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524434, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101497', 'abnormal ciliary axoneme', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524435, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0116433', 'abnormal axis specification', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524436, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100429', 'abnormal spermatid', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524437, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101569', 'abnormal activin-induced ectoderm', 0.47058823529411764, 1.4755025719078136, 0.8332791557971614, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524438, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141960', 'absent cilium motility in brain', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524439, 'HP:0034701', 'Corneal amyloidosis', 'XPO:00000000', 'Xenopus phenotype', 0.5714285714285714, 1.4755025719078136, 0.918228907628411, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524440, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0107284', 'abnormal migrating myoblast', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524441, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100626', 'abnormal primordial germ cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524442, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101373', 'abnormal oxygen accumulating cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524443, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100581', 'abnormal immune system', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524444, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0133401', 'absent determination of left/right symmetry in lateral plate mesoderm', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524445, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100642', 'abnormal gustatory system', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524446, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0115509', 'abnormally semi-viable whole organism', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524447, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100585', 'abnormal elastica externa', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524448, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101575', 'abnormal vitelline membrane', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524449, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101570', 'abnormal forelimb region', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524450, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141315', 'abnormal anatomical region', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524451, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141789', 'abnormal hormone catabolic process', 0.4583333333333333, 4.758907843651163, 1.4768771428276568, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524452, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141600', 'absent metamorphosis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524453, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100152', 'abnormal alimentary system', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524454, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141778', 'abnormal biosynthetic process', 0.55, 4.758907843651163, 1.6178378515809735, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524455, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100802', 'abnormal exocrine cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524456, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100862', 'abnormal blastomere V1', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524457, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0133403', 'abnormal developmental process', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524458, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100501', 'abnormal urogenital system', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524459, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131694', 'abnormal RNA polymerase II activity', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524460, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101109', 'abnormal egg cell-free extract', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524461, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0115505', 'dead whole organism', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524462, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100010', 'abnormal multicellular anatomical structure', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524463, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100888', 'abnormal microtubule', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524464, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101405', 'abnormal ring structure', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524465, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0107253', 'abnormal enteric nervous system', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524466, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141874', 'abnormal creatinine metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524467, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141783', 'abnormal collagen metabolic process', 0.55, 4.758907843651163, 1.6178378515809735, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524468, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100887', 'abnormal right-dorsal blastomere', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524469, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100006', 'abnormal anatomical structure', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524470, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141271', 'increased surface breathing', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524471, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101366', 'abnormal morula cell', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524472, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141975', 'abnormal cilium motility', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524473, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131677', 'abnormal actin filament', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524474, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0107262', 'abnormal left-right axis', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524475, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101333', 'abnormal barrier epithelial cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524476, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141883', 'abnormal glycerol metabolic process', 0.44, 4.758907843651163, 1.447038165082909, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524477, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100842', 'abnormal left-dorsal blastomere', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524478, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100653', 'abnormal myoblast', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524479, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100715', 'abnormal ciliated cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524480, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100239', 'abnormal acellular anatomical structure', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524481, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100427', 'abnormal olfactory system', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524482, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100026', 'abnormal germ cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524483, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141272', 'absent surface breathing', 0.5333333333333333, 1.4755025719078136, 0.8870934026456857, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524484, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141743', 'abnormal chemical homeostasis within a tissue', 0.5333333333333333, 1.4755025719078136, 0.8870934026456857, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524485, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100317', 'abnormal respiratory system', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524486, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100503', 'abnormal blastomere D2', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524487, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141911', 'abnormal ribose phosphate metabolic process', 0.4782608695652174, 4.758907843651163, 1.508641575552437, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524488, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141782', 'abnormal methylation', 0.55, 4.758907843651163, 1.6178378515809735, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524489, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100108', 'abnormal cell part', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524490, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0115508', 'abnormally peramorphic growth of whole organism', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524491, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131469', 'abnormal heart process', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524492, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101311', 'abnormal bottle cell', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524493, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100004', 'abnormal cell', 0.5, 1.8210412618256888, 0.954212047143005, 'HP:0000118', 'Phenotypic abnormality'),
(524494, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100899', 'abnormal secondary spermatogonium', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524495, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141748', 'abnormal gas homeostasis', 0.5333333333333333, 1.4755025719078136, 0.8870934026456857, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524496, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131685', 'abnormal cortical actin cytoskeleton', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524497, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100674', 'abnormal secondary oogonium', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524498, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141762', 'abnormal multicellular organismal water homeostasis', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524499, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101228', 'abnormal mesenchymal stem cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524500, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100070', 'abnormal anatomical system', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524501, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101461', 'abnormal sperm entry point', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524502, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141964', 'absent cilium motility in olfactory pit', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524503, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0107276', 'abnormal dorsal region', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524504, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141872', 'abnormal cholesterol metabolic process', 0.4230769230769231, 4.758907843651163, 1.418937661667548, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524505, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141786', 'abnormal pigment metabolic process', 0.55, 4.758907843651163, 1.6178378515809735, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524506, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100308', 'abnormal early embryonic cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524507, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141785', 'abnormal thyroid hormone metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524508, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100218', 'abnormal epithelial cell', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524509, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141856', 'abnormal glycerolipid metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524510, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141899', 'abnormal mandelate metabolic process', 0.4074074074074074, 4.758907843651163, 1.392413123563799, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524511, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101480', 'abnormal stage V oocyte', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524512, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100852', 'abnormal interdigital region', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524513, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131666', 'abnormal adherens junction', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524514, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100417', 'abnormal dense regular connective tissue', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524515, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131719', 'abnormal activation of meiosis', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524516, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100423', 'abnormal process', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524517, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141959', 'absent cilium motility in floor plate', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524518, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0116494', 'absent biological process', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524519, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141795', 'abnormal glycosylation', 0.5, 4.758907843651163, 1.5425478669479211, 'HP:0001939', 'Abnormality of metabolism/homeostasis'),
(524520, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100081', 'abnormal anatomical entity in vitro', 0.5, 1.4755025719078136, 0.8589244937443028, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524521, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101472', 'abnormal zygote cortex', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524522, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100392', 'abnormal cilium', 0.43478260869565216, 1.8210412618256888, 0.8898073220416851, 'HP:0000118', 'Phenotypic abnormality'),
(524523, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141724', 'abnormal prevention of polyspermy', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524524, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0107273', 'abnormal basal region', 0.42105263157894735, 1.4755025719078136, 0.7882031722869998, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524525, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141266', 'abnormal surface breathing', 0.5333333333333333, 1.4755025719078136, 0.8870934026456857, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524526, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0131669', 'abnormal Roux spot', 0.4166666666666667, 1.8210412618256888, 0.871072438105678, 'HP:0000118', 'Phenotypic abnormality'),
(524527, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0101297', 'abnormal barrier cell', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
(524528, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100976', 'abnormal multiciliated cell', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524529, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100573', 'abnormal extraembryonic structure', 0.4444444444444444, 1.4755025719078136, 0.8098017787384251, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524530, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100721', 'abnormal centromere', 0.45454545454545453, 1.8210412618256888, 0.9098054891583067, 'HP:0000118', 'Phenotypic abnormality'),
(524531, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0141263', 'abnormal visually guided collision avoidance behavior', 0.5333333333333333, 1.4755025719078136, 0.8870934026456857, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(524532, 'HP:0034701', 'Corneal amyloidosis', 'XPO:0100337', 'abnormal zygote', 0.47619047619047616, 1.8210412618256888, 0.9312156064152277, 'HP:0000118', 'Phenotypic abnormality'),
